Materiały źródłowe

• #1 Mayo Clinic Health Library – Malignant peripheral nerve sheath tumors | Swiss Medical Network

  https://www.swissmedical.net/en/healtcare-library/con-20313998

  Malignant peripheral nerve sheath tumors can happen anywhere in the body. They mostly occur in the deep tissue of the arms, legs and trunk. They tend to cause pain and weakness where they occur. They might also cause a growing lump or mass. […] Malignant peripheral nerve sheath tumors often cause symptoms that get worse quickly. Symptoms include: Pain where the tumor is growing. Weakness when trying to move the body part that has the tumor. A growing lump of tissue under the skin.

• #2 Malignant peripheral nerve sheath tumors

  https://johnsonmemorial.org/jmh-health/disease-conditions/con-20313998

  Malignant peripheral nerve sheath tumors often cause symptoms that get worse quickly. Symptoms include: Pain where the tumor is growing. Weakness when trying to move the body part that has the tumor. A growing lump of tissue under the skin. […] They tend to cause pain and weakness where they occur. They might also cause a growing lump or mass.

• #2 Malignant Peripheral Nerve Sheath Tumor (MPNST)

  https://my.clevelandclinic.org/health/diseases/malignant-peripheral-nerve-sheath-tumor-mpnst

  Malignant peripheral nerve sheath tumors (MPNSTs) affect nerves that manage your muscles and sense of touch. In MPNST, cells that make up nerves protective shield become cancerous and multiply to develop tumors. Its a very rare cancer that grows very quickly. The most common treatment is surgery to remove the tumors, but they often come back. […] MPNSTs develop anywhere you have peripheral nerves, but they typically affect places like your arms and legs. They can appear in your pelvis, chest, abdomen or head and neck. MPNST symptoms may include: A lump under your skin that keeps growing. These tumors may be as small as a pea (about 2 centimeters) or as large as a grapefruit (about 10 cm). Pain (especially if you have NF1). Paresthesia (tingling). Weakness in your arms and legs. […] Your prognosis is what your healthcare team believes will happen after you finish treatment. They base MPNST prognoses on several factors: NF1 status: The prognosis for people with NF1 who have these tumors is less positive than the prognosis for people who dont have NF1. Tumor grade: Pathologists classify tumors as being high-grade or low-grade, based on how cells appear when viewed under a microscope. High-grade tumors have cancerous cells that divide very quickly and are likely to spread. Tumor size: MPNSTs may grow up to 10 centimeters. In general, large tumors are more difficult to remove with surgery. Metastasis: Tumors that spread from where they started are more difficult to treat. […] If you have a malignant peripheral nerve sheath tumor, youre dealing with a rare cancer that often comes back after treatment.

• #3 What Are Malignant Peripheral Nerve Sheath Tumors?

  https://www.rwjbh.org/treatment-care/neuroscience/neurology/conditions/malignant-peripheral-nerve-sheath-tumors/

  Malignant peripheral nerve sheath tumors are most common in young adults and middle-aged adults, and more than half are found in people who have neurofibromatosis 1 (a non-cancerous condition that causes bone deformities). […] In the early stages, malignant peripheral nerve sheath tumors may not have many symptoms. As a tumor grows and presses on the nerves, symptoms may include: Pain, Weakness, A growing lump or mass under the skin.

• #4 Malignant Peripheral Nerve Sheath Tumor – NCI

  https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-soft-tissue-tumors/mpnst

  Some people with MPNST do not have symptoms at first. Later, when the tumor gets larger, symptoms can include: pain, weakness, a growing lump under the skin. […] The five-year survival rate for people with MPNST is between 23% and 69%. How long someone with MPNST lives depends on the size of the tumor and where it is in the body. People with smaller tumors tend to live longer than people whose cancer has spread to other parts of the body.

• #5 Malignant peripheral nerve sheath tumors

  https://johnsonmemorial.org/jmh-health/disease-conditions/con-20313998

  Malignant peripheral nerve sheath tumors often cause symptoms that get worse quickly. Symptoms include: Pain where the tumor is growing. Weakness when trying to move the body part that has the tumor. A growing lump of tissue under the skin. […] They tend to cause pain and weakness where they occur. They might also cause a growing lump or mass.

• #6

  https://www.aurorahealthcare.org/services/neuroscience/brain-skull-base-care/peripheral-nerve-tumors/malignant-peripheral-nerve-sheath-tumor

  Malignant peripheral nerve sheath tumors (MPNST) are a type of soft tissue sarcoma. […] Symptoms of malignant peripheral nerve sheath tumors may not appear when tumors are still small. Common symptoms of larger tumors include: Pain, tingling or weakness in the affected area, noticeable growths under the skin, changes in sensitivity to touch, temperature or pain. […] When a malignant peripheral nerve sheath tumor grows, it damages the myelin of the nerve sheath and disrupts the messages that travel through nerves to and from your central nervous system (brain and spine). They grow quickly and may be resistant to treatment. […] MPNST cancers tend to return after being removed through surgery or other treatments. When they return, theyre also known to spread (metastasize) to the lungs.

• #7 Malignant Peripheral Nerve Sheath Tumor (MPNST)

  https://my.clevelandclinic.org/health/diseases/malignant-peripheral-nerve-sheath-tumor-mpnst

  Malignant peripheral nerve sheath tumors (MPNSTs) affect nerves that manage your muscles and sense of touch. In MPNST, cells that make up nerves protective shield become cancerous and multiply to develop tumors. Its a very rare cancer that grows very quickly. The most common treatment is surgery to remove the tumors, but they often come back. […] MPNSTs develop anywhere you have peripheral nerves, but they typically affect places like your arms and legs. They can appear in your pelvis, chest, abdomen or head and neck. MPNST symptoms may include: A lump under your skin that keeps growing. These tumors may be as small as a pea (about 2 centimeters) or as large as a grapefruit (about 10 cm). Pain (especially if you have NF1). Paresthesia (tingling). Weakness in your arms and legs. […] Your prognosis is what your healthcare team believes will happen after you finish treatment. They base MPNST prognoses on several factors: NF1 status: The prognosis for people with NF1 who have these tumors is less positive than the prognosis for people who dont have NF1. Tumor grade: Pathologists classify tumors as being high-grade or low-grade, based on how cells appear when viewed under a microscope. High-grade tumors have cancerous cells that divide very quickly and are likely to spread. Tumor size: MPNSTs may grow up to 10 centimeters. In general, large tumors are more difficult to remove with surgery. Metastasis: Tumors that spread from where they started are more difficult to treat. […] If you have a malignant peripheral nerve sheath tumor, youre dealing with a rare cancer that often comes back after treatment.

• #8 Nerve Sheath Tumors: Types, Symptoms, Treatment, Outlook

  https://www.healthline.com/health/nerve-sheath-tumor

  Nerve sheath tumors are rare tumors that grow on the lining of nerve cells. Symptoms differ depending on whether the tumors are cranial, spinal, or peripheral. Theyre usually benign, but malignant cases may require aggressive treatment. […] Symptoms include pain, numbness, and weakness. You may also feel a lump or mass beneath the skin. […] Although rare, malignant nerve sheath tumors grow and spread rapidly and require more aggressive treatment. […] The symptoms of a nerve sheath tumor may include: pain, facial paralysis, numbness or tingling, weakness, tinnitus, loss of hearing, balance problems, a lump or lumps below the skin. […] If you have any symptoms of nerve sheath tumors or if you feel any sort of lump or nodules growing under the skin, schedule an appointment with your doctor. Though rare, MPNSTs are aggressive and spread quickly. Its important not to delay diagnosis and treatment.

• #9 Pain as a symptom of peripheral nerve sheath tumors: clinical significance and future therapeutic directions

  https://pmc.ncbi.nlm.nih.gov/articles/PMC2291052/

  Tumors arising from the supporting cells of peripheral nerve sheaths are relatively uncommon neoplasms, and as such many clinicians are unfamiliar with the details of their presentation, diagnosis and management. Further, little is known regarding the pathogenesis of these tumors, how they cause symptoms, and how to treat these symptoms. […] The typical presenting signs and symptoms of a peripheral nerve sheath tumor (PNST) involves some combination of a palpable (or radiographically visible) mass involving a peripheral nerve, loss of nerve function, and/or pain. […] Of clear importance is the ability to differentiate between benign and malignant lesions as early as possible in the clinical work-up and management of these lesions, as they are treated very differently, and exhibit very different clinical and intraoperative behaviors.

• #10 Pain as a symptom of peripheral nerve sheath tumors: clinical significance and future therapeutic directions

  https://pmc.ncbi.nlm.nih.gov/articles/PMC2291052/

  Current evidence suggests that in most cases, benign and malignant lesions can be differentiated pre-operatively based on clinical and radiographic characteristics. […] Less clear is what to make of pain in the setting of a PNST, as approximately 75% of all patients with PNST (benign or malignant) have pain in some setting, and the positive predictive value of the symptom „pain” to predict malignancy is about 20-30%. […] Thus, further clarification of the character and timing of the pain increases the PPV of the symptom „pain” to 75%, making it a much more useful piece of information in surgical planning. […] Some form of pain is seen in most patients with peripheral nerve tumor, regardless of their histopathology. However, careful delineation of the nature and character of the pain seems to provide valuable information for planning the surgical approach to these tumors. Lesions with a significant degree of rest pain should be considered as potentially malignant in terms of pre-surgical planning.

• #11 Pain as a symptom of peripheral nerve sheath tumors: clinical significance and future therapeutic directions

  https://pmc.ncbi.nlm.nih.gov/articles/PMC2291052/

  Current evidence suggests that in most cases, benign and malignant lesions can be differentiated pre-operatively based on clinical and radiographic characteristics. […] Less clear is what to make of pain in the setting of a PNST, as approximately 75% of all patients with PNST (benign or malignant) have pain in some setting, and the positive predictive value of the symptom „pain” to predict malignancy is about 20-30%. […] Thus, further clarification of the character and timing of the pain increases the PPV of the symptom „pain” to 75%, making it a much more useful piece of information in surgical planning. […] Some form of pain is seen in most patients with peripheral nerve tumor, regardless of their histopathology. However, careful delineation of the nature and character of the pain seems to provide valuable information for planning the surgical approach to these tumors. Lesions with a significant degree of rest pain should be considered as potentially malignant in terms of pre-surgical planning.

• #12

  https://www.aurorahealthcare.org/services/neuroscience/brain-skull-base-care/peripheral-nerve-tumors/malignant-peripheral-nerve-sheath-tumor

  Malignant peripheral nerve sheath tumors (MPNST) are a type of soft tissue sarcoma. […] Symptoms of malignant peripheral nerve sheath tumors may not appear when tumors are still small. Common symptoms of larger tumors include: Pain, tingling or weakness in the affected area, noticeable growths under the skin, changes in sensitivity to touch, temperature or pain. […] When a malignant peripheral nerve sheath tumor grows, it damages the myelin of the nerve sheath and disrupts the messages that travel through nerves to and from your central nervous system (brain and spine). They grow quickly and may be resistant to treatment. […] MPNST cancers tend to return after being removed through surgery or other treatments. When they return, theyre also known to spread (metastasize) to the lungs.

• #13

  https://www.advocatehealth.com/health-services/brain-spine-institute/peripheral-nerve-tumors/malignant-peripheral-nerve-sheath-tumor

  Malignant peripheral nerve sheath tumors are cancerous. MPNSTs grow quickly and may be resistant to treatment. They tend to return after being removed through surgery or other treatments. When they return, theyre also known to spread, or metastasize, to the lungs. […] Symptoms often start after theyve grown bigger and may include: Pain, tingling or weakness in the affected area, Growing lump under the skin, Changes in sensitivity to touch, temperature or pain.

• #14 Malignant peripheral nerve sheath tumor – Wikipedia

  https://en.wikipedia.org/wiki/Malignant_peripheral_nerve_sheath_tumor

  Symptoms may include: […] Swelling in the extremities (arms or legs), also called peripheral edema; the swelling often is painless. […] Difficulty in moving the extremity that has the tumor, including a limp. […] Soreness localized to the area of the tumor or in the extremity. […] Neurological symptoms. […] Pain or discomfort: numbness, burning, or „pins and needles”. […] Dizziness and/or loss of balance. […] Metastasis occurs in about 39% of patients, most commonly to the lung. […] Features associated with poor prognosis include a large primary tumor (over 5 cm across), high grade disease, co-existent neurofibromatosis, and the presence of metastases. […] It is a rare tumor type, with a relatively poor prognosis in children. […] In addition, MPNSTs are extremely threatening in NF1.

• #15 Treatment for Peripheral Nerve Tumors

  https://www.rwjbh.org/treatment-care/neuroscience/neurosurgery/conditions-treated/peripheral-nerve-tumors/

  Signs and symptoms of peripheral nerve sheath tumors vary based on which tissues they affect, but in general include a painful, swollen lump under the skin, weakness, loss of function in the area, and dizziness or difficulty balancing. […] Peripheral nerve tumors become problematic when they interfere with normal activities, cause pain, weakness, numbness, and tingling. […] If your peripheral nerve sheath tumor is cancerous, it may be treated with a combination of surgery, chemo, and radiation therapy, but tumors may recur after treatment and/or spread to other areas of the body.

• #16 Malignant peripheral nerve sheath tumor – Wikipedia

  https://en.wikipedia.org/wiki/Malignant_peripheral_nerve_sheath_tumor

  Symptoms may include: […] Swelling in the extremities (arms or legs), also called peripheral edema; the swelling often is painless. […] Difficulty in moving the extremity that has the tumor, including a limp. […] Soreness localized to the area of the tumor or in the extremity. […] Neurological symptoms. […] Pain or discomfort: numbness, burning, or „pins and needles”. […] Dizziness and/or loss of balance. […] Metastasis occurs in about 39% of patients, most commonly to the lung. […] Features associated with poor prognosis include a large primary tumor (over 5 cm across), high grade disease, co-existent neurofibromatosis, and the presence of metastases. […] It is a rare tumor type, with a relatively poor prognosis in children. […] In addition, MPNSTs are extremely threatening in NF1.

• #17 Giant intrapelvic malignant peripheral nerve sheath tumor mimicking disc herniation: A case report

  https://www.spandidos-publications.com/10.3892/mco.2016.1030

  Giant intrapelvic malignant peripheral nerve sheath tumors arising in the sciatic nerve in the pelvic cavity are a rare occurrence and their symptomatology is usually misdiagnosed as intervertebral disc herniation. […] The most common clinical presentation of intrapelvic MPNST consists of radicular and distal pain, paraesthesia and motor deficiencies. […] Since the symptoms are similar to sciatica due to a herniated disk, while imaging of the spine may reveal discopathy, intrapelvic MPNST of the sciatic nerve is easily misdiagnosed. […] Patients with MPNST have a poor prognosis. Adverse prognostic factors include large size, high-grade tumor, proximal location, surgical margin with tumor invasion and NF1. […] Our goal was to emphasize that intrapelvic MPNST, although infrequent, should be included in the differential diagnosis of sciatica, as its symptomatology may mimic disc herniation.

• #18 Peripheral nerve tumors – UpToDate

  https://www.uptodate.com/contents/peripheral-nerve-tumors

  Symptoms and signs – Patients present for evaluation of peripheral nerve tumors because of a soft tissue mass, pain, or focal neurologic findings, approximately in that order of frequency. […] The duration and progression of symptoms or signs are important, as most benign tumors have a longer duration and a slow rate of progression, while malignant tumors tend to progress rapidly in size, amount of pain, and neurologic deficit.

• #19 Nerve Sheath Tumors: Types, Symptoms, Treatment, Outlook

  https://www.healthline.com/health/nerve-sheath-tumor

  Nerve sheath tumors are rare tumors that grow on the lining of nerve cells. Symptoms differ depending on whether the tumors are cranial, spinal, or peripheral. Theyre usually benign, but malignant cases may require aggressive treatment. […] Symptoms include pain, numbness, and weakness. You may also feel a lump or mass beneath the skin. […] Although rare, malignant nerve sheath tumors grow and spread rapidly and require more aggressive treatment. […] The symptoms of a nerve sheath tumor may include: pain, facial paralysis, numbness or tingling, weakness, tinnitus, loss of hearing, balance problems, a lump or lumps below the skin. […] If you have any symptoms of nerve sheath tumors or if you feel any sort of lump or nodules growing under the skin, schedule an appointment with your doctor. Though rare, MPNSTs are aggressive and spread quickly. Its important not to delay diagnosis and treatment.

• #20 Malignant Peripheral Nerve Sheath Tumors: Latest Concepts in Disease Pathogenesis and Clinical Management

  https://www.mdpi.com/2072-6694/15/4/1077

  Malignant peripheral nerve sheath tumor (MPNST) is a soft tissue sarcoma with limited therapeutic interventions and a poor prognosis. The main clinical manifestations are pain and numbness; however, they are not specific symptoms, and MPNSTs are difficult to distinguish from other nerve lesions. MPNST is still difficult to diagnose and treat, and the overall prognosis is poor. Although MPNST is a rare disease, the mortality rate is high. The median survival time is largely based on subtypes of MPNST and molecular variations. MPNST development may also be influenced by genetic differences between ethnic groups. […] The average age of onset is around 30–50 years, although, in NF1 patients, it may occur 10 years earlier on average. It occurs mainly in the proximal limbs, followed by the trunk, head, and neck.

• #21 Malignant Peripheral Nerve Sheath Tumors: Latest Concepts in Disease Pathogenesis and Clinical Management

  https://www.mdpi.com/2072-6694/15/4/1077

  There are limited treatment options for MPNST, and the only effective treatment is complete surgical resection to achieve negative margins. According to data, gross-total resection results in lower recurrence and higher five-years survival rates. Additionally, patients with negative tumor margins have a relatively higher survival rate than those with positive margins. […] The five-year overall survival rate is 50–60%, and the median survival of MPNST is six years. The identification of prognostic predictors is necessary for accurate diagnosis and treatment selection.

• #22 A Discussion of Malignant Peripheral Nerve Sheath Tumors (MPNSTs) – Neurofibromatosis Program

  https://www.uab.edu/medicine/nfprogram/blog/blog-archive/a-discussion-of-malignant-peripheral-nerve-sheath-tumors-mpnsts

  The focus of this months blog post is a discussion of malignant peripheral nerve sheath tumors (MPNSTs), which represent one of the few potentially life-threatening complications of neurofibromatosis type 1. […] MPNSTs occur mostly in teens and young adults with NF1. These tumors usually arise from pre-existing plexiform or nodular neurofibromas and do not originate from cutaneous neurofibromas (i.e., the small tumors on the skin). […] The following are indications that a tumor requires medical evaluation: […] Persistent, unexplained pain. Most neurofibromas are not painful, so occurrence of pain, which is often attributed to other causes, is a sign the tumor should be medically checked. […] Rapid growth of a tumor. Although neurofibromas may grow, the sudden growth of a tumor or growth that is significantly out of proportion to other neurofibromas should be evaluated.

• #23 A Discussion of Malignant Peripheral Nerve Sheath Tumors (MPNSTs) – Neurofibromatosis Program

  https://www.uab.edu/medicine/nfprogram/blog/blog-archive/a-discussion-of-malignant-peripheral-nerve-sheath-tumors-mpnsts

  Change in the consistency of a tumor from soft to hard. Most neurofibromas are soft and spongy, although firm nodular neurofibromas under the skin are not worrisome. […] Treatment of MPNSTs usually involves surgery to resect the tumor, if possible. […] In conclusion, because MPNSTs are difficult to treat, early detection is critically important. Individuals with NF1 should report instances of chronic pain or rapidly growing tumors.

• #24 Surgical management of craniospinal axis malignant peripheral nerve sheath tumors: a single-institution experience and literature review | World Journal of Surgical Oncology | Full Text

  https://wjso.biomedcentral.com/articles/10.1186/s12957-023-03227-y

  Malignant peripheral nerve sheath tumor (MPNST) is an exceedingly rare and aggressive tumor, with limited literature on its management. […] The most common presenting symptoms were paresthesia (50%) and visual changes (13%). […] MPNSTs are characterized by aggressive local invasiveness and high rates of both local recurrence and distant metastases. […] When arising within the craniospinal axis, they can cause symptoms secondary to mass effect, resulting in spinal cord compression, cranial nerve palsies, and focal neurologic deficits based on tumor location. […] Patients with primary intradural MPNST often present with insidious neurological symptoms, which are generally attributable to a progressive mass effect on nearby neurovascular structures. When present in the cranium, symptoms include headache, nausea/vomiting, seizures, focal neurological deficits, and/or cranial nerve palsies. When present in the spine, MPNST may cause myelopathic symptoms, pain, motor weakness, sensory deficit/radiculopathy, and bowel/bladder dysfunction.

• #25 Malignant peripheral nerve sheath tumor | About the Disease | GARD

  https://rarediseases.info.nih.gov/diseases/10872/malignant-peripheral-nerve-sheath-tumor

  A Malignant peripheral nerve sheath tumor (MPNST) is a tumor that develops in the protective lining that covers nerves. The first symptom of MPNST is often a lump or mass that increases in size, sometimes causing pain or a tingling sensation. MPNST is considered an aggressive tumor because there is up to a 65% chance of the tumor regrowing after surgery (a recurrence), and approximately 40% chance of spreading to distant parts of the body (a metastasis), most commonly to the lung. Approximately 25-50% of MPNSTs are associated with a genetic condition known as neurofibromatosis type 1. […] Symptoms of this disease may start to appear at a variety of ages.

• #26 Nerve Sheath Tumors: Types, Symptoms, Treatment, Outlook

  https://www.healthline.com/health/nerve-sheath-tumor

  MPNST can grow and spread quickly. It may be resistant to chemotherapy and often return after treatment. According to the National Institutes of Health, MPNST has a 65% chance of coming back after surgery (recurrence) and a 40% chance of spreading (metastasis). These tumors may require aggressive treatment for the best outcome. […] In rare cases, nerve sheath tumors can become cancerous and may require aggressive treatment.

• #27 Malignant peripheral nerve sheath tumor – Wikipedia

  https://en.wikipedia.org/wiki/Malignant_peripheral_nerve_sheath_tumor

  Symptoms may include: […] Swelling in the extremities (arms or legs), also called peripheral edema; the swelling often is painless. […] Difficulty in moving the extremity that has the tumor, including a limp. […] Soreness localized to the area of the tumor or in the extremity. […] Neurological symptoms. […] Pain or discomfort: numbness, burning, or „pins and needles”. […] Dizziness and/or loss of balance. […] Metastasis occurs in about 39% of patients, most commonly to the lung. […] Features associated with poor prognosis include a large primary tumor (over 5 cm across), high grade disease, co-existent neurofibromatosis, and the presence of metastases. […] It is a rare tumor type, with a relatively poor prognosis in children. […] In addition, MPNSTs are extremely threatening in NF1.

• #28 Malignant peripheral nerve sheath tumor – Wikipedia

  https://en.wikipedia.org/wiki/Malignant_peripheral_nerve_sheath_tumor

  Symptoms may include: […] Swelling in the extremities (arms or legs), also called peripheral edema; the swelling often is painless. […] Difficulty in moving the extremity that has the tumor, including a limp. […] Soreness localized to the area of the tumor or in the extremity. […] Neurological symptoms. […] Pain or discomfort: numbness, burning, or „pins and needles”. […] Dizziness and/or loss of balance. […] Metastasis occurs in about 39% of patients, most commonly to the lung. […] Features associated with poor prognosis include a large primary tumor (over 5 cm across), high grade disease, co-existent neurofibromatosis, and the presence of metastases. […] It is a rare tumor type, with a relatively poor prognosis in children. […] In addition, MPNSTs are extremely threatening in NF1.

• #29 Malignant peripheral nerve sheath tumor | About the Disease | GARD

  https://rarediseases.info.nih.gov/diseases/10872/malignant-peripheral-nerve-sheath-tumor

  A Malignant peripheral nerve sheath tumor (MPNST) is a tumor that develops in the protective lining that covers nerves. The first symptom of MPNST is often a lump or mass that increases in size, sometimes causing pain or a tingling sensation. MPNST is considered an aggressive tumor because there is up to a 65% chance of the tumor regrowing after surgery (a recurrence), and approximately 40% chance of spreading to distant parts of the body (a metastasis), most commonly to the lung. Approximately 25-50% of MPNSTs are associated with a genetic condition known as neurofibromatosis type 1. […] Symptoms of this disease may start to appear at a variety of ages.

• #30 Morphologic and immunohistochemical features of malignant peripheral nerve sheath tumors and cellular schwannomas | Modern Pathology

  https://www.nature.com/articles/modpathol2014109

  Malignant peripheral nerve sheath tumors are malignant neoplasms arising from peripheral nerve or extraneural soft tissue that display evidence of nerve sheath differentiation. […] For individuals harboring a malignant peripheral nerve sheath tumor, despite adjuvant chemotherapy and radiation, the overall prognosis is poor, with 5-year disease-specific survival ranging between 35 and 50%. […] In a large cohort, 41% of patients who initially presented with a localized malignant peripheral nerve sheath tumor developed distant metastasis in a median time of 12 months. […] Among malignant peripheral nerve sheath tumors, 13 (11%) were low grade and 102 (89%) high grade, including 20% diagnosed as malignant Triton tumors. […] There were 10 (17%) patients who had metastasis at the time of initial diagnosis, and 12 additional patients who developed metastases during follow-up (median 16.8 months, range: 5.357.1).

• #31 Morphologic and immunohistochemical features of malignant peripheral nerve sheath tumors and cellular schwannomas | Modern Pathology

  https://www.nature.com/articles/modpathol2014109

  The most common site of metastasis was lung (12 patients, 55%). […] Overall, cellular schwannoma patients had significantly better progression-free and disease-specific survival times than malignant peripheral nerve sheath tumor patients (P<0.001, for both). [...] Five-year progression-free survival rates were 17.7% for malignant peripheral nerve sheath tumor and 100% for cellular schwannoma, and 5-year disease-specific survival rates were 31.9% for malignant peripheral nerve sheath tumor and 100% for cellular schwannoma. [...] In striking contrast, 37.3% of patients with malignant peripheral nerve sheath tumors had metastases and the 5-year disease-specific survival rate was 31.9%.

• #32

  https://link.springer.com/article/10.1007/s11523-024-01078-5

  In addition to frequent metastasis and disease recurrence, patients with MPNST are also approximately 30 times more likely than the general population to develop secondary malignancies, particularly in the breast, skin, lung, and soft tissues in females as well as skin and myeloid tissues in males. […] The prognosis is poor, with typically rapid growth and metastasis (mainly to the lungs more often than the bone or liver).

• #33 Morphologic and immunohistochemical features of malignant peripheral nerve sheath tumors and cellular schwannomas | Modern Pathology

  https://www.nature.com/articles/modpathol2014109

  Malignant peripheral nerve sheath tumors are malignant neoplasms arising from peripheral nerve or extraneural soft tissue that display evidence of nerve sheath differentiation. […] For individuals harboring a malignant peripheral nerve sheath tumor, despite adjuvant chemotherapy and radiation, the overall prognosis is poor, with 5-year disease-specific survival ranging between 35 and 50%. […] In a large cohort, 41% of patients who initially presented with a localized malignant peripheral nerve sheath tumor developed distant metastasis in a median time of 12 months. […] Among malignant peripheral nerve sheath tumors, 13 (11%) were low grade and 102 (89%) high grade, including 20% diagnosed as malignant Triton tumors. […] There were 10 (17%) patients who had metastasis at the time of initial diagnosis, and 12 additional patients who developed metastases during follow-up (median 16.8 months, range: 5.357.1).

• #34 Malignant Peripheral Nerve Sheath Tumors: Latest Concepts in Disease Pathogenesis and Clinical Management

  https://www.mdpi.com/2072-6694/15/4/1077

  Malignant peripheral nerve sheath tumor (MPNST) is a soft tissue sarcoma with limited therapeutic interventions and a poor prognosis. The main clinical manifestations are pain and numbness; however, they are not specific symptoms, and MPNSTs are difficult to distinguish from other nerve lesions. MPNST is still difficult to diagnose and treat, and the overall prognosis is poor. Although MPNST is a rare disease, the mortality rate is high. The median survival time is largely based on subtypes of MPNST and molecular variations. MPNST development may also be influenced by genetic differences between ethnic groups. […] The average age of onset is around 30–50 years, although, in NF1 patients, it may occur 10 years earlier on average. It occurs mainly in the proximal limbs, followed by the trunk, head, and neck.

• #35 Malignant Peripheral Nerve Sheath Tumors: Latest Concepts in Disease Pathogenesis and Clinical Management

  https://www.mdpi.com/2072-6694/15/4/1077

  MPNST is the leading cause of premature death in NF1 patients. Clinical symptoms are mainly used to diagnose NF1. […] The risk of post-radiation sarcoma in patients who undergo radiation therapy has been reported to be about 0.06%. Approximately 10–13% of MPNST patients have a history of therapeutic irradiation. […] The probability of malignant progression to MPNST is 10–15%. PN is commonly detected in childhood and grows rapidly during that period. Growth in adulthood is usually indicative of malignancy potential. […] In clinical manifestations, it is difficult to distinguish PN from MPNST since they both exhibit similar neurological symptoms (pain, neurologic impairment, and motor dysfunction) and disfigurement. Some PN patients remain asymptomatic throughout their lives. […] The long-term outcome of radiation therapy results in excellent local control. However, adjuvant radiation therapy is not beneficial in MPNST survival, even though, in some studies, adjuvant radiation has been used to reduce the tumor size in order to make surgery possible.

• #36 Malignant Peripheral Nerve Sheath Tumor (MPNST)

  https://my.clevelandclinic.org/health/diseases/malignant-peripheral-nerve-sheath-tumor-mpnst

  Malignant peripheral nerve sheath tumors (MPNSTs) affect nerves that manage your muscles and sense of touch. In MPNST, cells that make up nerves protective shield become cancerous and multiply to develop tumors. Its a very rare cancer that grows very quickly. The most common treatment is surgery to remove the tumors, but they often come back. […] MPNSTs develop anywhere you have peripheral nerves, but they typically affect places like your arms and legs. They can appear in your pelvis, chest, abdomen or head and neck. MPNST symptoms may include: A lump under your skin that keeps growing. These tumors may be as small as a pea (about 2 centimeters) or as large as a grapefruit (about 10 cm). Pain (especially if you have NF1). Paresthesia (tingling). Weakness in your arms and legs. […] Your prognosis is what your healthcare team believes will happen after you finish treatment. They base MPNST prognoses on several factors: NF1 status: The prognosis for people with NF1 who have these tumors is less positive than the prognosis for people who dont have NF1. Tumor grade: Pathologists classify tumors as being high-grade or low-grade, based on how cells appear when viewed under a microscope. High-grade tumors have cancerous cells that divide very quickly and are likely to spread. Tumor size: MPNSTs may grow up to 10 centimeters. In general, large tumors are more difficult to remove with surgery. Metastasis: Tumors that spread from where they started are more difficult to treat. […] If you have a malignant peripheral nerve sheath tumor, youre dealing with a rare cancer that often comes back after treatment.

• #37 Malignant Peripheral Nerve Sheath Tumour – SFA

  https://curesarcoma.org/sarcoma-subtypes/malignant-peripheral-nerve-sheath-tumour/

  Malignant peripheral nerve sheath tumor is a rare and aggressive soft tissue sarcoma that typically arises from peripheral nerves or benign nerve sheath tumors, often associated with neurofibromatosis type 1. […] MPNSTs are typically seen in patients aged 20–50 years; rarely do they arise in children, usually in the setting of NF1. Patients with NF1 are usually younger at the time of diagnosis than patients with sporadic tumors. The presenting symptoms are an enlarging painful or painless mass that may be palpable or identified on imaging studies. When the tumor involves a nerve, the patient may present with neuropathic symptoms such as motor weakness, paraesthesia, or radicular pain. […] MPNST is an aggressive tumor with a poor prognosis. Truncal location, tumor size > 5 cm, local recurrence, and high-grade morphology are all adverse prognostic factors; patients with NF1-associated MPNST appear to have a worse prognosis than patients with sporadic tumors. Malignant triton tumors are particularly aggressive.

• #38 Malignant peripheral nerve sheath tumor – Wikipedia

  https://en.wikipedia.org/wiki/Malignant_peripheral_nerve_sheath_tumor

  Symptoms may include: […] Swelling in the extremities (arms or legs), also called peripheral edema; the swelling often is painless. […] Difficulty in moving the extremity that has the tumor, including a limp. […] Soreness localized to the area of the tumor or in the extremity. […] Neurological symptoms. […] Pain or discomfort: numbness, burning, or „pins and needles”. […] Dizziness and/or loss of balance. […] Metastasis occurs in about 39% of patients, most commonly to the lung. […] Features associated with poor prognosis include a large primary tumor (over 5 cm across), high grade disease, co-existent neurofibromatosis, and the presence of metastases. […] It is a rare tumor type, with a relatively poor prognosis in children. […] In addition, MPNSTs are extremely threatening in NF1.

• #39 Malignant Peripheral Nerve Sheath Tumour – SFA

  https://curesarcoma.org/sarcoma-subtypes/malignant-peripheral-nerve-sheath-tumour/

  Malignant peripheral nerve sheath tumor is a rare and aggressive soft tissue sarcoma that typically arises from peripheral nerves or benign nerve sheath tumors, often associated with neurofibromatosis type 1. […] MPNSTs are typically seen in patients aged 20–50 years; rarely do they arise in children, usually in the setting of NF1. Patients with NF1 are usually younger at the time of diagnosis than patients with sporadic tumors. The presenting symptoms are an enlarging painful or painless mass that may be palpable or identified on imaging studies. When the tumor involves a nerve, the patient may present with neuropathic symptoms such as motor weakness, paraesthesia, or radicular pain. […] MPNST is an aggressive tumor with a poor prognosis. Truncal location, tumor size > 5 cm, local recurrence, and high-grade morphology are all adverse prognostic factors; patients with NF1-associated MPNST appear to have a worse prognosis than patients with sporadic tumors. Malignant triton tumors are particularly aggressive.

• #40 Morphologic and immunohistochemical features of malignant peripheral nerve sheath tumors and cellular schwannomas | Modern Pathology

  https://www.nature.com/articles/modpathol2014109

  Malignant peripheral nerve sheath tumors are malignant neoplasms arising from peripheral nerve or extraneural soft tissue that display evidence of nerve sheath differentiation. […] For individuals harboring a malignant peripheral nerve sheath tumor, despite adjuvant chemotherapy and radiation, the overall prognosis is poor, with 5-year disease-specific survival ranging between 35 and 50%. […] In a large cohort, 41% of patients who initially presented with a localized malignant peripheral nerve sheath tumor developed distant metastasis in a median time of 12 months. […] Among malignant peripheral nerve sheath tumors, 13 (11%) were low grade and 102 (89%) high grade, including 20% diagnosed as malignant Triton tumors. […] There were 10 (17%) patients who had metastasis at the time of initial diagnosis, and 12 additional patients who developed metastases during follow-up (median 16.8 months, range: 5.357.1).

• #41 Malignant Peripheral Nerve Sheath Tumour – SFA

  https://curesarcoma.org/sarcoma-subtypes/malignant-peripheral-nerve-sheath-tumour/

  Malignant peripheral nerve sheath tumor is a rare and aggressive soft tissue sarcoma that typically arises from peripheral nerves or benign nerve sheath tumors, often associated with neurofibromatosis type 1. […] MPNSTs are typically seen in patients aged 20–50 years; rarely do they arise in children, usually in the setting of NF1. Patients with NF1 are usually younger at the time of diagnosis than patients with sporadic tumors. The presenting symptoms are an enlarging painful or painless mass that may be palpable or identified on imaging studies. When the tumor involves a nerve, the patient may present with neuropathic symptoms such as motor weakness, paraesthesia, or radicular pain. […] MPNST is an aggressive tumor with a poor prognosis. Truncal location, tumor size > 5 cm, local recurrence, and high-grade morphology are all adverse prognostic factors; patients with NF1-associated MPNST appear to have a worse prognosis than patients with sporadic tumors. Malignant triton tumors are particularly aggressive.

• #42 Orphanet: Malignant peripheral nerve sheath tumor

  https://www.orpha.net/en/disease/detail/3148

  Malignant peripheral nerve sheath tumor (MPNST) is a rare and often aggressive soft tissue sarcoma occurring in a wide range of anatomical sites. […] The age of occurrence is highly variable but most cases are reported in adults (typically between 20 and 50 years of age). In most cases, tumors arise in major nerve trunks such as the sciatic nerve or in the brachial plexus and sacral plexus. They are highly variable in appearance and commonly present as a rapidly enlarging palpable mass that is sometimes painful, with associated neurologic deficits such as radicular pain, paresthesia, and motor weakness. […] Tumors are often aggressive and high-grade, with the tendency to recur or to metastasize. […] Prognosis is generally poor and depends on the size of the tumor and success of treatment. A less favorable prognosis is associated with large tumors, NF1-associated cases, and truncal localization. The recurrence rate is reported to be as high as 40% and approximately two thirds of cases metastasize (lungs and bone). Five-year survival rate is reported to be 26% to 60%, and 10-year survival to be around 45%.

• #43 Malignant Peripheral Nerve Sheath Tumors: Latest Concepts in Disease Pathogenesis and Clinical Management

  https://www.mdpi.com/2072-6694/15/4/1077

  MPNST is the leading cause of premature death in NF1 patients. Clinical symptoms are mainly used to diagnose NF1. […] The risk of post-radiation sarcoma in patients who undergo radiation therapy has been reported to be about 0.06%. Approximately 10–13% of MPNST patients have a history of therapeutic irradiation. […] The probability of malignant progression to MPNST is 10–15%. PN is commonly detected in childhood and grows rapidly during that period. Growth in adulthood is usually indicative of malignancy potential. […] In clinical manifestations, it is difficult to distinguish PN from MPNST since they both exhibit similar neurological symptoms (pain, neurologic impairment, and motor dysfunction) and disfigurement. Some PN patients remain asymptomatic throughout their lives. […] The long-term outcome of radiation therapy results in excellent local control. However, adjuvant radiation therapy is not beneficial in MPNST survival, even though, in some studies, adjuvant radiation has been used to reduce the tumor size in order to make surgery possible.

• #44 Malignant Peripheral Nerve Sheath Tumors: Latest Concepts in Disease Pathogenesis and Clinical Management

  https://www.mdpi.com/2072-6694/15/4/1077

  MPNST is the leading cause of premature death in NF1 patients. Clinical symptoms are mainly used to diagnose NF1. […] The risk of post-radiation sarcoma in patients who undergo radiation therapy has been reported to be about 0.06%. Approximately 10–13% of MPNST patients have a history of therapeutic irradiation. […] The probability of malignant progression to MPNST is 10–15%. PN is commonly detected in childhood and grows rapidly during that period. Growth in adulthood is usually indicative of malignancy potential. […] In clinical manifestations, it is difficult to distinguish PN from MPNST since they both exhibit similar neurological symptoms (pain, neurologic impairment, and motor dysfunction) and disfigurement. Some PN patients remain asymptomatic throughout their lives. […] The long-term outcome of radiation therapy results in excellent local control. However, adjuvant radiation therapy is not beneficial in MPNST survival, even though, in some studies, adjuvant radiation has been used to reduce the tumor size in order to make surgery possible.

• #45 Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities | Nature Communications

  https://www.nature.com/articles/s41467-023-38432-6

  Malignant peripheral nerve sheath tumors (MPNSTs) represent a highly aggressive and lethal subtype of peripheral nerve sheath tumors (PNSTs) that confer a 5-year survival rate as low as 2050%. Approximately half of all MPNSTs occur in the setting of the hereditary neurofibromatosis type 1 (NF1) tumor predisposition syndrome, which afflicts 1 in 3000 individuals. The hallmark of NF1 is the development of PNSTs that fall within a spectrum of benign (cutaneous and intraneural neurofibromas) and malignant (MPNST). Plexiform intraneural neurofibromas are present in around 3050% of NF1 patients and harbor a 515% lifetime risk of malignant transformation. Recently, atypical neurofibromas have been described with premalignant features consisting of increased cellularity, cytological atypia and/or a fascicular growth pattern. On the malignant end of the spectrum, MPNSTs are sarcomas causing an average reduction in life expectancy by 510 years in the NF1 population. Standard of care includes maximal surgical resection with adjuvant radiation therapy, with few effective chemotherapies presently available. Limited advances in the clinical outcome of these aggressive sarcomas reflect gaps in knowledge in the mechanism of malignant transformation and lack of candidates in the therapeutic pipeline.

• #46 Malignant Peripheral Nerve Sheath Tumors: Latest Concepts in Disease Pathogenesis and Clinical Management

  https://www.mdpi.com/2072-6694/15/4/1077

  MPNST is the leading cause of premature death in NF1 patients. Clinical symptoms are mainly used to diagnose NF1. […] The risk of post-radiation sarcoma in patients who undergo radiation therapy has been reported to be about 0.06%. Approximately 10–13% of MPNST patients have a history of therapeutic irradiation. […] The probability of malignant progression to MPNST is 10–15%. PN is commonly detected in childhood and grows rapidly during that period. Growth in adulthood is usually indicative of malignancy potential. […] In clinical manifestations, it is difficult to distinguish PN from MPNST since they both exhibit similar neurological symptoms (pain, neurologic impairment, and motor dysfunction) and disfigurement. Some PN patients remain asymptomatic throughout their lives. […] The long-term outcome of radiation therapy results in excellent local control. However, adjuvant radiation therapy is not beneficial in MPNST survival, even though, in some studies, adjuvant radiation has been used to reduce the tumor size in order to make surgery possible.

• #47 Malignant Peripheral Nerve Sheath Tumors: Latest Concepts in Disease Pathogenesis and Clinical Management

  https://www.mdpi.com/2072-6694/15/4/1077

  MPNST is the leading cause of premature death in NF1 patients. Clinical symptoms are mainly used to diagnose NF1. […] The risk of post-radiation sarcoma in patients who undergo radiation therapy has been reported to be about 0.06%. Approximately 10–13% of MPNST patients have a history of therapeutic irradiation. […] The probability of malignant progression to MPNST is 10–15%. PN is commonly detected in childhood and grows rapidly during that period. Growth in adulthood is usually indicative of malignancy potential. […] In clinical manifestations, it is difficult to distinguish PN from MPNST since they both exhibit similar neurological symptoms (pain, neurologic impairment, and motor dysfunction) and disfigurement. Some PN patients remain asymptomatic throughout their lives. […] The long-term outcome of radiation therapy results in excellent local control. However, adjuvant radiation therapy is not beneficial in MPNST survival, even though, in some studies, adjuvant radiation has been used to reduce the tumor size in order to make surgery possible.

• #48 Malignant Peripheral Nerve Sheath Tumors – Rein in Sarcoma

  https://www.reininsarcoma.org/mpnst/

  Malignant schwannoma, also known as a malignant peripheral nerve sheath tumor (MPNST), is a type of soft tissue sarcoma that originates in the lining (sheath) of peripheral nerves that emerge from the spinal cord. […] A malignant transformation of a benign plexiform neurofibroma may first present as new, intensifying or persistent pain localized to the pre-existing mass. In a patient without NF1, a malignant nerve sheath tumor may manifest as pain arising from an entirely new, rapidly enlarging mass. As a result of the tumors mass effect in either etiology, local neurological symptoms of weakness or paresthesia may also develop. […] The most common sites of malignant peripheral nerve sheath tumors include the nerve roots in the proximal extremities and pelvis, especially in the sciatic nerve. […] Depending on the etiology, MPNSTs classically present as either new pain in a pre-existing lesion or pain in an entirely new, rapidly enlarging mass, often located in the proximal extremity.

• #49 Malignant Peripheral Nerve Sheath Tumor – NCI

  https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-soft-tissue-tumors/mpnst

  Some people with MPNST do not have symptoms at first. Later, when the tumor gets larger, symptoms can include: pain, weakness, a growing lump under the skin. […] The five-year survival rate for people with MPNST is between 23% and 69%. How long someone with MPNST lives depends on the size of the tumor and where it is in the body. People with smaller tumors tend to live longer than people whose cancer has spread to other parts of the body.

• #50 Peripheral Nerve Sheath Tumors | Neurological Surgery

  https://neurosurgery.weillcornell.org/condition/peripheral-nerve-sheath-tumors

  Neurosurgeons are experts in not only in the central nervous system (the brain and spine) but also the peripheral nervous system, which branches all over the body. […] In some cases, however, they can cause debilitating pain, sensory issues, and weakness or paralysis of a particular muscle group if left untreated. […] MPNSTs are a rare subtype of sarcomas that arise from the cells surrounding nerves. These are aggressive, cancerous growths. These tumors can grow rapidly. Treatment may consist of a combination of surgery, chemotherapy, and radiation therapy. Even with optimal and timely therapy, these tumors can metastasize to other parts of the body and have a 5-year survival rate of 23-69%.

• #51 Malignant Peripheral Nerve Sheath Tumors: Latest Concepts in Disease Pathogenesis and Clinical Management

  https://www.mdpi.com/2072-6694/15/4/1077

  There are limited treatment options for MPNST, and the only effective treatment is complete surgical resection to achieve negative margins. According to data, gross-total resection results in lower recurrence and higher five-years survival rates. Additionally, patients with negative tumor margins have a relatively higher survival rate than those with positive margins. […] The five-year overall survival rate is 50–60%, and the median survival of MPNST is six years. The identification of prognostic predictors is necessary for accurate diagnosis and treatment selection.

• #52 Orphanet: Malignant peripheral nerve sheath tumor

  https://www.orpha.net/en/disease/detail/3148

  Malignant peripheral nerve sheath tumor (MPNST) is a rare and often aggressive soft tissue sarcoma occurring in a wide range of anatomical sites. […] The age of occurrence is highly variable but most cases are reported in adults (typically between 20 and 50 years of age). In most cases, tumors arise in major nerve trunks such as the sciatic nerve or in the brachial plexus and sacral plexus. They are highly variable in appearance and commonly present as a rapidly enlarging palpable mass that is sometimes painful, with associated neurologic deficits such as radicular pain, paresthesia, and motor weakness. […] Tumors are often aggressive and high-grade, with the tendency to recur or to metastasize. […] Prognosis is generally poor and depends on the size of the tumor and success of treatment. A less favorable prognosis is associated with large tumors, NF1-associated cases, and truncal localization. The recurrence rate is reported to be as high as 40% and approximately two thirds of cases metastasize (lungs and bone). Five-year survival rate is reported to be 26% to 60%, and 10-year survival to be around 45%.

• #53 Malignant Peripheral Nerve Sheath Tumor – NCI

  https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-soft-tissue-tumors/mpnst

  Some people with MPNST do not have symptoms at first. Later, when the tumor gets larger, symptoms can include: pain, weakness, a growing lump under the skin. […] The five-year survival rate for people with MPNST is between 23% and 69%. How long someone with MPNST lives depends on the size of the tumor and where it is in the body. People with smaller tumors tend to live longer than people whose cancer has spread to other parts of the body.

• #54 Peripheral Nerve Sheath Tumors | Neurological Surgery

  https://neurosurgery.weillcornell.org/condition/peripheral-nerve-sheath-tumors

  Neurosurgeons are experts in not only in the central nervous system (the brain and spine) but also the peripheral nervous system, which branches all over the body. […] In some cases, however, they can cause debilitating pain, sensory issues, and weakness or paralysis of a particular muscle group if left untreated. […] MPNSTs are a rare subtype of sarcomas that arise from the cells surrounding nerves. These are aggressive, cancerous growths. These tumors can grow rapidly. Treatment may consist of a combination of surgery, chemotherapy, and radiation therapy. Even with optimal and timely therapy, these tumors can metastasize to other parts of the body and have a 5-year survival rate of 23-69%.

• #55 Orphanet: Malignant peripheral nerve sheath tumor

  https://www.orpha.net/en/disease/detail/3148

  Malignant peripheral nerve sheath tumor (MPNST) is a rare and often aggressive soft tissue sarcoma occurring in a wide range of anatomical sites. […] The age of occurrence is highly variable but most cases are reported in adults (typically between 20 and 50 years of age). In most cases, tumors arise in major nerve trunks such as the sciatic nerve or in the brachial plexus and sacral plexus. They are highly variable in appearance and commonly present as a rapidly enlarging palpable mass that is sometimes painful, with associated neurologic deficits such as radicular pain, paresthesia, and motor weakness. […] Tumors are often aggressive and high-grade, with the tendency to recur or to metastasize. […] Prognosis is generally poor and depends on the size of the tumor and success of treatment. A less favorable prognosis is associated with large tumors, NF1-associated cases, and truncal localization. The recurrence rate is reported to be as high as 40% and approximately two thirds of cases metastasize (lungs and bone). Five-year survival rate is reported to be 26% to 60%, and 10-year survival to be around 45%.

• #56 Malignant Peripheral Nerve Sheath Tumors: Latest Concepts in Disease Pathogenesis and Clinical Management

  https://www.mdpi.com/2072-6694/15/4/1077

  There are limited treatment options for MPNST, and the only effective treatment is complete surgical resection to achieve negative margins. According to data, gross-total resection results in lower recurrence and higher five-years survival rates. Additionally, patients with negative tumor margins have a relatively higher survival rate than those with positive margins. […] The five-year overall survival rate is 50–60%, and the median survival of MPNST is six years. The identification of prognostic predictors is necessary for accurate diagnosis and treatment selection.

• #57

  https://link.springer.com/article/10.1007/s11523-024-01078-5

  Malignant peripheral sheath tumor (MPNST) is a rare, aggressive form of soft-tissue sarcoma that presents a unique set of diagnostic and treatment challenges and is associated with major unmet treatment medical needs. […] MPNSTs often exhibit extensive nerve involvement and infiltration of surrounding structures, which can render them inoperable. The median OS and progression-free survival (PFS) in patients with unresectable MPNST are less than 5 and 2 months, respectively, in trials of investigational agents. […] MPNST typically presents as a soft-tissue mass or swelling, often enlarging over a period of several months, with potential local/radicular pain, paresthesia, or paraparesis (on disease progression). Mixed sensory and motor symptoms are suggestive findings because neurologic deficits are infrequent in patients with benign masses.

• #58 Malignant peripheral nerve sheath tumor – Wikipedia

  https://en.wikipedia.org/wiki/Malignant_peripheral_nerve_sheath_tumor

  Symptoms may include: […] Swelling in the extremities (arms or legs), also called peripheral edema; the swelling often is painless. […] Difficulty in moving the extremity that has the tumor, including a limp. […] Soreness localized to the area of the tumor or in the extremity. […] Neurological symptoms. […] Pain or discomfort: numbness, burning, or „pins and needles”. […] Dizziness and/or loss of balance. […] Metastasis occurs in about 39% of patients, most commonly to the lung. […] Features associated with poor prognosis include a large primary tumor (over 5 cm across), high grade disease, co-existent neurofibromatosis, and the presence of metastases. […] It is a rare tumor type, with a relatively poor prognosis in children. […] In addition, MPNSTs are extremely threatening in NF1.

• #59 Malignant Peripheral Nerve Sheath Tumour – SFA

  https://curesarcoma.org/sarcoma-subtypes/malignant-peripheral-nerve-sheath-tumour/

  Malignant peripheral nerve sheath tumor is a rare and aggressive soft tissue sarcoma that typically arises from peripheral nerves or benign nerve sheath tumors, often associated with neurofibromatosis type 1. […] MPNSTs are typically seen in patients aged 20–50 years; rarely do they arise in children, usually in the setting of NF1. Patients with NF1 are usually younger at the time of diagnosis than patients with sporadic tumors. The presenting symptoms are an enlarging painful or painless mass that may be palpable or identified on imaging studies. When the tumor involves a nerve, the patient may present with neuropathic symptoms such as motor weakness, paraesthesia, or radicular pain. […] MPNST is an aggressive tumor with a poor prognosis. Truncal location, tumor size > 5 cm, local recurrence, and high-grade morphology are all adverse prognostic factors; patients with NF1-associated MPNST appear to have a worse prognosis than patients with sporadic tumors. Malignant triton tumors are particularly aggressive.

• #60 Malignant Peripheral Nerve Sheath Tumor – NCI

  https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-soft-tissue-tumors/mpnst

  Some people with MPNST do not have symptoms at first. Later, when the tumor gets larger, symptoms can include: pain, weakness, a growing lump under the skin. […] The five-year survival rate for people with MPNST is between 23% and 69%. How long someone with MPNST lives depends on the size of the tumor and where it is in the body. People with smaller tumors tend to live longer than people whose cancer has spread to other parts of the body.

• #61

  https://journals.lww.com/jcraniofacialsurgery/fulltext/2022/11000/malignant_peripheral_nerve_sheath_tumor_of_the.78.aspx

  Four patients with diagnosis of malignant peripheral nerve sheath tumor (MPNST) was treated at the Department of Oral and Maxillofacial Surgery (Nanjing Stomatological Hospital, Medical School of Nanjing University) from 2005 to 2020. […] The most common symptom was rapidly enlarging mass with no nerve palsy associated. […] Malignant peripheral nerve sheath tumor has a high degree of malignancy and active growth of tumor tissue. Patients often show tissue swelling and pain caused by compression of surrounding tissue. At the same time, the tumor originated from the peripheral nerve, which can be converted into local numbness or dyskinesia. […] In addition to local tissue swelling, pain and neurological symptoms, MPNST in oral and maxillofacial region can also show swallowing and language disorders.

• #62 Malignant Peripheral Nerve Sheath Tumour – SFA

  https://curesarcoma.org/sarcoma-subtypes/malignant-peripheral-nerve-sheath-tumour/

  Malignant peripheral nerve sheath tumor is a rare and aggressive soft tissue sarcoma that typically arises from peripheral nerves or benign nerve sheath tumors, often associated with neurofibromatosis type 1. […] MPNSTs are typically seen in patients aged 20–50 years; rarely do they arise in children, usually in the setting of NF1. Patients with NF1 are usually younger at the time of diagnosis than patients with sporadic tumors. The presenting symptoms are an enlarging painful or painless mass that may be palpable or identified on imaging studies. When the tumor involves a nerve, the patient may present with neuropathic symptoms such as motor weakness, paraesthesia, or radicular pain. […] MPNST is an aggressive tumor with a poor prognosis. Truncal location, tumor size > 5 cm, local recurrence, and high-grade morphology are all adverse prognostic factors; patients with NF1-associated MPNST appear to have a worse prognosis than patients with sporadic tumors. Malignant triton tumors are particularly aggressive.

• #63 Orphanet: Malignant peripheral nerve sheath tumor

  https://www.orpha.net/en/disease/detail/3148

  Malignant peripheral nerve sheath tumor (MPNST) is a rare and often aggressive soft tissue sarcoma occurring in a wide range of anatomical sites. […] The age of occurrence is highly variable but most cases are reported in adults (typically between 20 and 50 years of age). In most cases, tumors arise in major nerve trunks such as the sciatic nerve or in the brachial plexus and sacral plexus. They are highly variable in appearance and commonly present as a rapidly enlarging palpable mass that is sometimes painful, with associated neurologic deficits such as radicular pain, paresthesia, and motor weakness. […] Tumors are often aggressive and high-grade, with the tendency to recur or to metastasize. […] Prognosis is generally poor and depends on the size of the tumor and success of treatment. A less favorable prognosis is associated with large tumors, NF1-associated cases, and truncal localization. The recurrence rate is reported to be as high as 40% and approximately two thirds of cases metastasize (lungs and bone). Five-year survival rate is reported to be 26% to 60%, and 10-year survival to be around 45%.

• #64 Malignant Peripheral Nerve Sheath Tumor (MPNST)

  https://my.clevelandclinic.org/health/diseases/malignant-peripheral-nerve-sheath-tumor-mpnst

  Malignant peripheral nerve sheath tumors (MPNSTs) affect nerves that manage your muscles and sense of touch. In MPNST, cells that make up nerves protective shield become cancerous and multiply to develop tumors. Its a very rare cancer that grows very quickly. The most common treatment is surgery to remove the tumors, but they often come back. […] MPNSTs develop anywhere you have peripheral nerves, but they typically affect places like your arms and legs. They can appear in your pelvis, chest, abdomen or head and neck. MPNST symptoms may include: A lump under your skin that keeps growing. These tumors may be as small as a pea (about 2 centimeters) or as large as a grapefruit (about 10 cm). Pain (especially if you have NF1). Paresthesia (tingling). Weakness in your arms and legs. […] Your prognosis is what your healthcare team believes will happen after you finish treatment. They base MPNST prognoses on several factors: NF1 status: The prognosis for people with NF1 who have these tumors is less positive than the prognosis for people who dont have NF1. Tumor grade: Pathologists classify tumors as being high-grade or low-grade, based on how cells appear when viewed under a microscope. High-grade tumors have cancerous cells that divide very quickly and are likely to spread. Tumor size: MPNSTs may grow up to 10 centimeters. In general, large tumors are more difficult to remove with surgery. Metastasis: Tumors that spread from where they started are more difficult to treat. […] If you have a malignant peripheral nerve sheath tumor, youre dealing with a rare cancer that often comes back after treatment.

• #65 Malignant Peripheral Nerve Sheath Tumour – SFA

  https://curesarcoma.org/sarcoma-subtypes/malignant-peripheral-nerve-sheath-tumour/

  Malignant peripheral nerve sheath tumor is a rare and aggressive soft tissue sarcoma that typically arises from peripheral nerves or benign nerve sheath tumors, often associated with neurofibromatosis type 1. […] MPNSTs are typically seen in patients aged 20–50 years; rarely do they arise in children, usually in the setting of NF1. Patients with NF1 are usually younger at the time of diagnosis than patients with sporadic tumors. The presenting symptoms are an enlarging painful or painless mass that may be palpable or identified on imaging studies. When the tumor involves a nerve, the patient may present with neuropathic symptoms such as motor weakness, paraesthesia, or radicular pain. […] MPNST is an aggressive tumor with a poor prognosis. Truncal location, tumor size > 5 cm, local recurrence, and high-grade morphology are all adverse prognostic factors; patients with NF1-associated MPNST appear to have a worse prognosis than patients with sporadic tumors. Malignant triton tumors are particularly aggressive.

• #66 Morphologic and immunohistochemical features of malignant peripheral nerve sheath tumors and cellular schwannomas | Modern Pathology

  https://www.nature.com/articles/modpathol2014109

  Malignant peripheral nerve sheath tumors are malignant neoplasms arising from peripheral nerve or extraneural soft tissue that display evidence of nerve sheath differentiation. […] For individuals harboring a malignant peripheral nerve sheath tumor, despite adjuvant chemotherapy and radiation, the overall prognosis is poor, with 5-year disease-specific survival ranging between 35 and 50%. […] In a large cohort, 41% of patients who initially presented with a localized malignant peripheral nerve sheath tumor developed distant metastasis in a median time of 12 months. […] Among malignant peripheral nerve sheath tumors, 13 (11%) were low grade and 102 (89%) high grade, including 20% diagnosed as malignant Triton tumors. […] There were 10 (17%) patients who had metastasis at the time of initial diagnosis, and 12 additional patients who developed metastases during follow-up (median 16.8 months, range: 5.357.1).

• #67 Malignant Peripheral Nerve Sheath Tumors: Latest Concepts in Disease Pathogenesis and Clinical Management

  https://www.mdpi.com/2072-6694/15/4/1077

  There are limited treatment options for MPNST, and the only effective treatment is complete surgical resection to achieve negative margins. According to data, gross-total resection results in lower recurrence and higher five-years survival rates. Additionally, patients with negative tumor margins have a relatively higher survival rate than those with positive margins. […] The five-year overall survival rate is 50–60%, and the median survival of MPNST is six years. The identification of prognostic predictors is necessary for accurate diagnosis and treatment selection.

• #68 Malignant peripheral nerve sheath tumor – Wikipedia

  https://en.wikipedia.org/wiki/Malignant_peripheral_nerve_sheath_tumor

  Symptoms may include: […] Swelling in the extremities (arms or legs), also called peripheral edema; the swelling often is painless. […] Difficulty in moving the extremity that has the tumor, including a limp. […] Soreness localized to the area of the tumor or in the extremity. […] Neurological symptoms. […] Pain or discomfort: numbness, burning, or „pins and needles”. […] Dizziness and/or loss of balance. […] Metastasis occurs in about 39% of patients, most commonly to the lung. […] Features associated with poor prognosis include a large primary tumor (over 5 cm across), high grade disease, co-existent neurofibromatosis, and the presence of metastases. […] It is a rare tumor type, with a relatively poor prognosis in children. […] In addition, MPNSTs are extremely threatening in NF1.

• #69 Malignant peripheral nerve sheath tumour (MPNST) | Soft tissue sarcoma | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/soft-tissue-sarcoma/types/malignant-schwannoma

  Malignant peripheral nerve sheath tumours can be difficult to treat. […] The main treatment is surgery. Your surgeon aims to remove as much of the cancer as possible and the surrounding tissue. […] You might have radiotherapy before surgery. Radiotherapy aims to shrink the cancer, making it easier to remove. This is called neoadjuvant treatment. […] A malignant peripheral nerve sheath tumour can come back in the same place. This is called local recurrence. […] It can be more difficult to treat if the sarcoma comes back. You might have surgery again if it is possible to remove the new tumour.

• #70 Malignant peripheral nerve sheath tumor | About the Disease | GARD

  https://rarediseases.info.nih.gov/diseases/10872/malignant-peripheral-nerve-sheath-tumor

  A Malignant peripheral nerve sheath tumor (MPNST) is a tumor that develops in the protective lining that covers nerves. The first symptom of MPNST is often a lump or mass that increases in size, sometimes causing pain or a tingling sensation. MPNST is considered an aggressive tumor because there is up to a 65% chance of the tumor regrowing after surgery (a recurrence), and approximately 40% chance of spreading to distant parts of the body (a metastasis), most commonly to the lung. Approximately 25-50% of MPNSTs are associated with a genetic condition known as neurofibromatosis type 1. […] Symptoms of this disease may start to appear at a variety of ages.

• #71 Nerve Sheath Tumors: Types, Symptoms, Treatment, Outlook

  https://www.healthline.com/health/nerve-sheath-tumor

  MPNST can grow and spread quickly. It may be resistant to chemotherapy and often return after treatment. According to the National Institutes of Health, MPNST has a 65% chance of coming back after surgery (recurrence) and a 40% chance of spreading (metastasis). These tumors may require aggressive treatment for the best outcome. […] In rare cases, nerve sheath tumors can become cancerous and may require aggressive treatment.

• #72 Malignant peripheral nerve sheath tumor presenting in the cauda equina: diagnostic and biological pearls. Illustrative case in: Journal of Neurosurgery: Case Lessons Volume 9 Issue 12 (2025) Journals

  https://thejns.org/caselessons/view/journals/j-neurosurg-case-lessons/9/12/article-CASE24723.xml

  MPNSTs rarely present as an intradural extramedullary mass in the lumbar spine and have high local recurrence rates (20%85%) with poor survival (5-year overall survival: 15%66%). […] Resection, while the mainstay of treatment for this pathology, was deemed urgent due to the patients rapid functional decline. […] However, there are reports of recurrence rates after GTR as early as 714 months. […] Treatment for MPNST involves GTR with wide negative margins, aiming to achieve control of the tumor and improve survival in patients. […] In patients in whom the diagnosis of MPNST is questionable, who have accessible masses, and who do not have cauda equina syndrome, preoperative PET/CT-guided biopsy can be an effective means to obtain tissue for diagnosis and might be appropriate to help the physician and patient decide on the timing of surgery. […] In such cases in which tumors cannot be excised with wide margins, adjuvant radiotherapy has shown efficacy in gaining local control of the tumor, although its effect on overall survival is still controversial.

• #73 NEUROSARCOMA (MPNST) | Hand Surgery Resource

  https://www.handsurgeryresource.net/neurosarcoma

  Most patients with a MPNST tumor are between 20 and 50 years of age and preset with a complaint of an enlarging mass. […] Pain complaints are variable. […] Diagnosis and treatment are often delayed owing to the absence of symptoms or nonspecific symptoms. […] Tumor growth is aggressive, and the prognosis is poor. […] Symptoms include pain and progressive weakness and numbness in the affected area, lump or swelling, increasing in size and larger than 5 cm. […] Other symptoms such as paresthesias vary depending on the size and location of the tumor. […] There is a 65% chance of tumor recurrence after surgery. […] There is a 40% chance of metastasis upon regrowth, most commonly to the lung. […] The absence of a positive S100 antigen marker is associated with an increased risk of metastasis and death from these malignant nerve tumors.

• #74 Malignant peripheral nerve sheath tumour (MPNST) | Soft tissue sarcoma | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/soft-tissue-sarcoma/types/malignant-schwannoma

  Malignant peripheral nerve sheath tumours can be difficult to treat. […] The main treatment is surgery. Your surgeon aims to remove as much of the cancer as possible and the surrounding tissue. […] You might have radiotherapy before surgery. Radiotherapy aims to shrink the cancer, making it easier to remove. This is called neoadjuvant treatment. […] A malignant peripheral nerve sheath tumour can come back in the same place. This is called local recurrence. […] It can be more difficult to treat if the sarcoma comes back. You might have surgery again if it is possible to remove the new tumour.

• #75 Mayo Clinic Health Library – Malignant peripheral nerve sheath tumors | Swiss Medical Network

  https://www.swissmedical.net/en/healtcare-library/con-20313998

  Malignant peripheral nerve sheath tumors can happen anywhere in the body. They mostly occur in the deep tissue of the arms, legs and trunk. They tend to cause pain and weakness where they occur. They might also cause a growing lump or mass. […] Malignant peripheral nerve sheath tumors often cause symptoms that get worse quickly. Symptoms include: Pain where the tumor is growing. Weakness when trying to move the body part that has the tumor. A growing lump of tissue under the skin.

• #76 What Are Malignant Peripheral Nerve Sheath Tumors?

  https://www.rwjbh.org/treatment-care/neuroscience/neurology/conditions/malignant-peripheral-nerve-sheath-tumors/

  Malignant peripheral nerve sheath tumors are most common in young adults and middle-aged adults, and more than half are found in people who have neurofibromatosis 1 (a non-cancerous condition that causes bone deformities). […] In the early stages, malignant peripheral nerve sheath tumors may not have many symptoms. As a tumor grows and presses on the nerves, symptoms may include: Pain, Weakness, A growing lump or mass under the skin.

• #77 What Are Malignant Peripheral Nerve Sheath Tumors?

  https://www.rwjbh.org/treatment-care/neuroscience/neurology/conditions/malignant-peripheral-nerve-sheath-tumors/

  Malignant peripheral nerve sheath tumors are most common in young adults and middle-aged adults, and more than half are found in people who have neurofibromatosis 1 (a non-cancerous condition that causes bone deformities). […] In the early stages, malignant peripheral nerve sheath tumors may not have many symptoms. As a tumor grows and presses on the nerves, symptoms may include: Pain, Weakness, A growing lump or mass under the skin.

• #78

  https://www.advocatehealth.com/health-services/brain-spine-institute/peripheral-nerve-tumors/malignant-peripheral-nerve-sheath-tumor

  Malignant peripheral nerve sheath tumors are cancerous. MPNSTs grow quickly and may be resistant to treatment. They tend to return after being removed through surgery or other treatments. When they return, theyre also known to spread, or metastasize, to the lungs. […] Symptoms often start after theyve grown bigger and may include: Pain, tingling or weakness in the affected area, Growing lump under the skin, Changes in sensitivity to touch, temperature or pain.

• #79 Nerve Sheath Tumors: Definition & Types

  https://my.clevelandclinic.org/health/diseases/22526-nerve-sheath-tumors

  People with nerve sheath tumors often have no pain or other symptoms. If the tumor grows large or presses on the nerve, it may cause: […] Malignant peripheral nerve sheath tumors have a poor prognosis, especially if the tumor is larger than 2 inches. Fewer than half of people with this condition live five years after diagnosis.

• #80 Malignant peripheral nerve sheath tumour (MPNST) | Sarcoma UK

  https://sarcoma.org.uk/about-sarcoma/what-is-sarcoma/types-of-sarcoma/malignant-peripheral-nerve-sheath-tumour-mpnst/

  Symptoms of sarcoma can vary depending on the size and location of your tumour. You may experience all, some or none of these symptoms before you are diagnosed with a sarcoma: […] A lump or swelling in the soft tissue of the body under the skin, often on the arm, leg or trunk […] increasing in size […] is larger than 5cm […] usually painful, but not always.

• #81

  https://www.aurorahealthcare.org/services/neuroscience/brain-skull-base-care/peripheral-nerve-tumors

  A small percentage of neurofibromas and schwannomas can become malignant peripheral nerve sheath tumors (MPNSTs). These tumors are fast-growing and often grow on nerves in the legs, arms or pelvis. They can be resistant to chemotherapy treatment and often recur after treatment. […] Different peripheral nerve tumors have signs and symptoms that depend on the type of tumor and its size, location, and how fast it grows. […] Small, slow-growing tumors may have mild symptoms or even no symptoms. […] Signs and symptoms also vary depending on the person. However, some signs and symptoms that occur with many tumors include: Fatigue, Loss of movement, Pain, numbness or tingling in the affected body part, Visible lump or deformed appearance, Weakness. […] Malignant peripheral nerve sheath tumor treatment usually includes cancer surgery to remove as much of the tumor as possible. In extreme cases, surgery for an MPNST may require partial amputation of an affected limb. Radiation therapy and chemotherapy may be used before surgery to shrink the tumor, after surgery to remove the rest of the tumor, or both before and after surgery.

• #82 Mayo Clinic Health Library – Malignant peripheral nerve sheath tumors | Swiss Medical Network

  https://www.swissmedical.net/en/healtcare-library/con-20313998

  Malignant peripheral nerve sheath tumors can happen anywhere in the body. They mostly occur in the deep tissue of the arms, legs and trunk. They tend to cause pain and weakness where they occur. They might also cause a growing lump or mass. […] Malignant peripheral nerve sheath tumors often cause symptoms that get worse quickly. Symptoms include: Pain where the tumor is growing. Weakness when trying to move the body part that has the tumor. A growing lump of tissue under the skin.

• #83 Malignant peripheral nerve sheath tumors

  https://johnsonmemorial.org/jmh-health/disease-conditions/con-20313998

  Malignant peripheral nerve sheath tumors often cause symptoms that get worse quickly. Symptoms include: Pain where the tumor is growing. Weakness when trying to move the body part that has the tumor. A growing lump of tissue under the skin. […] They tend to cause pain and weakness where they occur. They might also cause a growing lump or mass.

• #84 Pain as a symptom of peripheral nerve sheath tumors: clinical significance and future therapeutic directions

  https://pmc.ncbi.nlm.nih.gov/articles/PMC2291052/

  Current evidence suggests that in most cases, benign and malignant lesions can be differentiated pre-operatively based on clinical and radiographic characteristics. […] Less clear is what to make of pain in the setting of a PNST, as approximately 75% of all patients with PNST (benign or malignant) have pain in some setting, and the positive predictive value of the symptom „pain” to predict malignancy is about 20-30%. […] Thus, further clarification of the character and timing of the pain increases the PPV of the symptom „pain” to 75%, making it a much more useful piece of information in surgical planning. […] Some form of pain is seen in most patients with peripheral nerve tumor, regardless of their histopathology. However, careful delineation of the nature and character of the pain seems to provide valuable information for planning the surgical approach to these tumors. Lesions with a significant degree of rest pain should be considered as potentially malignant in terms of pre-surgical planning.

• #85 Malignant Peripheral Nerve Sheath Tumor (MPNST)

  https://my.clevelandclinic.org/health/diseases/malignant-peripheral-nerve-sheath-tumor-mpnst

  Malignant peripheral nerve sheath tumors (MPNSTs) affect nerves that manage your muscles and sense of touch. In MPNST, cells that make up nerves protective shield become cancerous and multiply to develop tumors. Its a very rare cancer that grows very quickly. The most common treatment is surgery to remove the tumors, but they often come back. […] MPNSTs develop anywhere you have peripheral nerves, but they typically affect places like your arms and legs. They can appear in your pelvis, chest, abdomen or head and neck. MPNST symptoms may include: A lump under your skin that keeps growing. These tumors may be as small as a pea (about 2 centimeters) or as large as a grapefruit (about 10 cm). Pain (especially if you have NF1). Paresthesia (tingling). Weakness in your arms and legs. […] Your prognosis is what your healthcare team believes will happen after you finish treatment. They base MPNST prognoses on several factors: NF1 status: The prognosis for people with NF1 who have these tumors is less positive than the prognosis for people who dont have NF1. Tumor grade: Pathologists classify tumors as being high-grade or low-grade, based on how cells appear when viewed under a microscope. High-grade tumors have cancerous cells that divide very quickly and are likely to spread. Tumor size: MPNSTs may grow up to 10 centimeters. In general, large tumors are more difficult to remove with surgery. Metastasis: Tumors that spread from where they started are more difficult to treat. […] If you have a malignant peripheral nerve sheath tumor, youre dealing with a rare cancer that often comes back after treatment.

• #86 Malignant Peripheral Nerve Sheath Tumors – Rein in Sarcoma

  https://www.reininsarcoma.org/mpnst/

  Malignant schwannoma, also known as a malignant peripheral nerve sheath tumor (MPNST), is a type of soft tissue sarcoma that originates in the lining (sheath) of peripheral nerves that emerge from the spinal cord. […] A malignant transformation of a benign plexiform neurofibroma may first present as new, intensifying or persistent pain localized to the pre-existing mass. In a patient without NF1, a malignant nerve sheath tumor may manifest as pain arising from an entirely new, rapidly enlarging mass. As a result of the tumors mass effect in either etiology, local neurological symptoms of weakness or paresthesia may also develop. […] The most common sites of malignant peripheral nerve sheath tumors include the nerve roots in the proximal extremities and pelvis, especially in the sciatic nerve. […] Depending on the etiology, MPNSTs classically present as either new pain in a pre-existing lesion or pain in an entirely new, rapidly enlarging mass, often located in the proximal extremity.

• #87 Peripheral nerve tumors – Symptoms and causes – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/peripheral-nerve-tumors/symptoms-causes/syc-20355070

  Symptoms of peripheral nerve tumors vary depending on where the tumors are located and the tissues affected. They include: […] The symptoms of a peripheral nerve tumor develop from direct effects on the main nerve or from the tumor pressing on nearby nerves, blood vessels or tissues. As the tumor grows, it may be more likely to cause symptoms, although tumor size doesn’t always determine effects. […] Peripheral nerve tumors can press against nerves. This can lead to complications. Some may be permanent: […] Numbness and weakness in the affected area. […] Loss of function in the affected area. […] Trouble with balance. […] Pain.

• #88 Peripheral nerve tumors – Symptoms and causes – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/peripheral-nerve-tumors/symptoms-causes/syc-20355070

  Symptoms of peripheral nerve tumors vary depending on where the tumors are located and the tissues affected. They include: […] The symptoms of a peripheral nerve tumor develop from direct effects on the main nerve or from the tumor pressing on nearby nerves, blood vessels or tissues. As the tumor grows, it may be more likely to cause symptoms, although tumor size doesn’t always determine effects. […] Peripheral nerve tumors can press against nerves. This can lead to complications. Some may be permanent: […] Numbness and weakness in the affected area. […] Loss of function in the affected area. […] Trouble with balance. […] Pain.

• #89 Nerve Sheath Tumors: Types, Symptoms, Treatment, Outlook

  https://www.healthline.com/health/nerve-sheath-tumor

  Nerve sheath tumors are rare tumors that grow on the lining of nerve cells. Symptoms differ depending on whether the tumors are cranial, spinal, or peripheral. Theyre usually benign, but malignant cases may require aggressive treatment. […] Symptoms include pain, numbness, and weakness. You may also feel a lump or mass beneath the skin. […] Although rare, malignant nerve sheath tumors grow and spread rapidly and require more aggressive treatment. […] The symptoms of a nerve sheath tumor may include: pain, facial paralysis, numbness or tingling, weakness, tinnitus, loss of hearing, balance problems, a lump or lumps below the skin. […] If you have any symptoms of nerve sheath tumors or if you feel any sort of lump or nodules growing under the skin, schedule an appointment with your doctor. Though rare, MPNSTs are aggressive and spread quickly. Its important not to delay diagnosis and treatment.

• #90 Nerve Sheath Tumors | The National Canine Cancer Foundation

  https://wearethecure.org/learn-more-about-canine-cancer/canine-cancer-library/nerve-sheath-tumors/

  Malignant peripheral nerve sheath tumors (MPNSTs) are cancerous in nature. The lesions may appear as white, firm nodules. They tend to be locally aggressive. Although rare, these tumors can cause potential damage. However, peripheral nerve sheath tumors do not metastasize through the lymphatic system. […] It is very difficult to diagnose malignant peripheral nerve sheath tumors of the thoracic limb (forelimb). Clinically, most patients exhibit chronic progressive thoracic limb lameness, which cannot be distinguished from musculoskeletal lameness. A palpable axillary mass is seen in some of the cases. […] Normally the clinical signs include severe, unexplained, intractable pain, chronic, progressive forelimb lameness and muscle atrophy, lameness in the hind limbs, monoparesis (partial loss of movement of one extremity), ataxia (lack of coordination of muscle movements) and proprioceptive deficits (condition in which the dog is not aware of its movement and posture), peripheral nerve disorder (from self-mutilation), palpable mass (mass can be felt by touch examination), hypotonia (condition that causes reduced muscle strength), hyporeflexia (condition caused by absence of reflexes). Horners syndrome (symptom caused by damage to the sympathetic nervous system) and paresis are generally caused if the spinal cord is suppressed. If the schwannoma is in the neck, only one side of the face will be affected and eyelids would be droopy.

• #91 Peripheral Nerve Sheath Tumors in Dogs | PetCure Oncology

  https://petcureoncology.com/peripheral-nerve-sheath-tumors-in-dogs/

  Peripheral nerve sheath tumors in dogs are typically a single mass. They may be visible on the skin or you may feel a lump below the skin. The mass may be just a few millimeters in size but nerve sheath tumors also can grow much larger. […] A larger tumor could affect a stricken dog’s energy level, making him or her lethargic. He or she also could lose weight, even while maintaining a normal appetite. A larger tumor also could cause nerve impingement, impairing function or limiting a dog’s range of motion in a limb, for instance. A dog might appear to be dragging a limb or may even turn its paw over, walking on his or her knuckles with the pad facing upward, which is often referred to as knuckling. […] Though uncommon, when this type of cancer metastasizes, it will spread to the lungs or the local lymph nodes.

• #92 Giant intrapelvic malignant peripheral nerve sheath tumor mimicking disc herniation: A case report

  https://www.spandidos-publications.com/10.3892/mco.2016.1030

  Giant intrapelvic malignant peripheral nerve sheath tumors arising in the sciatic nerve in the pelvic cavity are a rare occurrence and their symptomatology is usually misdiagnosed as intervertebral disc herniation. […] The most common clinical presentation of intrapelvic MPNST consists of radicular and distal pain, paraesthesia and motor deficiencies. […] Since the symptoms are similar to sciatica due to a herniated disk, while imaging of the spine may reveal discopathy, intrapelvic MPNST of the sciatic nerve is easily misdiagnosed. […] Patients with MPNST have a poor prognosis. Adverse prognostic factors include large size, high-grade tumor, proximal location, surgical margin with tumor invasion and NF1. […] Our goal was to emphasize that intrapelvic MPNST, although infrequent, should be included in the differential diagnosis of sciatica, as its symptomatology may mimic disc herniation.

• #93

  https://journals.lww.com/jcraniofacialsurgery/fulltext/2022/11000/malignant_peripheral_nerve_sheath_tumor_of_the.78.aspx

  Four patients with diagnosis of malignant peripheral nerve sheath tumor (MPNST) was treated at the Department of Oral and Maxillofacial Surgery (Nanjing Stomatological Hospital, Medical School of Nanjing University) from 2005 to 2020. […] The most common symptom was rapidly enlarging mass with no nerve palsy associated. […] Malignant peripheral nerve sheath tumor has a high degree of malignancy and active growth of tumor tissue. Patients often show tissue swelling and pain caused by compression of surrounding tissue. At the same time, the tumor originated from the peripheral nerve, which can be converted into local numbness or dyskinesia. […] In addition to local tissue swelling, pain and neurological symptoms, MPNST in oral and maxillofacial region can also show swallowing and language disorders.

• #94 Neurofibrosarcoma and Schwannoma

  https://www.webmd.com/cancer/neurofibrosarcoma-and-schwannoma

  Neurofibrosarcomas usually affect the arms or legs but can also affect the head, neck, chest, abdomen, pelvis, and back. […] The symptoms of schwannoma and neurofibrosarcoma depend on where the tumor is, how large it is, and if it has spread. […] If you have a vestibular schwannoma, the symptoms are related to how the tumor is affecting the nerves in your inner ear and brain. It can cause: Hearing loss on one side, A feeling of fullness in one ear, Dizziness, Loss of balance, Tinnitus (ringing or other type of noise in the ear), Numbness in the face, Facial twitching, Facial weakness, Difficulty swallowing, Change in tear production, Headache and/or pressure in your head. […] Symptoms of a schwannoma in an arm or leg could include: Pain in the affected limb, Weakness, Tingling or pins-and-needles feeling, Carpel tunnel syndrome, Tarsal tunnel syndrome.

• #95 Mayo Clinic Health Library – Malignant peripheral nerve sheath tumors | Swiss Medical Network

  https://www.swissmedical.net/en/healtcare-library/con-20313998

  Malignant peripheral nerve sheath tumors can happen anywhere in the body. They mostly occur in the deep tissue of the arms, legs and trunk. They tend to cause pain and weakness where they occur. They might also cause a growing lump or mass. […] Malignant peripheral nerve sheath tumors often cause symptoms that get worse quickly. Symptoms include: Pain where the tumor is growing. Weakness when trying to move the body part that has the tumor. A growing lump of tissue under the skin.

• #96 Peripheral nerve tumors – UpToDate

  https://www.uptodate.com/contents/peripheral-nerve-tumors

  Symptoms and signs – Patients present for evaluation of peripheral nerve tumors because of a soft tissue mass, pain, or focal neurologic findings, approximately in that order of frequency. […] The duration and progression of symptoms or signs are important, as most benign tumors have a longer duration and a slow rate of progression, while malignant tumors tend to progress rapidly in size, amount of pain, and neurologic deficit.

• #97 Cauda equina malignant peripheral nerve sheath tumor presenting with subarachnoid hemorrhage: a case report | Neurocirugía (English edition)

  https://revistaneurocirugia.com/en-cauda-equina-malignant-peripheral-nerve-avance-S2529849624000583

  Malignant peripheral nerve sheath tumors (MPNST) are uncommon aggressive neoplasms, frequently associated with type I neurofibromatosis. […] Patients with MPNST have a poor prognosis with a 5-year survival rate from 16% to 44% with a local recurrence expected in 38-45% of cases. […] The most frequent clinical presentation of spinal canal MPNST is characterized by local or radicular pain and motor disturbances. […] The mean duration from onset of symptoms to preoperative diagnosis is 12.6 months. […] Our case presents notable findings in terms of the patient’s age, acute onset of symptoms, and the unique evidence of surgical subarachnoid hemorrhage (SSAH). […] The acute debut in our case could be explained by hemorrhage with secondary subarachnoid extension of the blood creating increase in the local pressure and roots irritation as the cause of back pain.

• #98 Malignant Peripheral Nerve Sheath Tumors: Latest Concepts in Disease Pathogenesis and Clinical Management

  https://www.mdpi.com/2072-6694/15/4/1077

  Malignant peripheral nerve sheath tumor (MPNST) is a soft tissue sarcoma with limited therapeutic interventions and a poor prognosis. The main clinical manifestations are pain and numbness; however, they are not specific symptoms, and MPNSTs are difficult to distinguish from other nerve lesions. MPNST is still difficult to diagnose and treat, and the overall prognosis is poor. Although MPNST is a rare disease, the mortality rate is high. The median survival time is largely based on subtypes of MPNST and molecular variations. MPNST development may also be influenced by genetic differences between ethnic groups. […] The average age of onset is around 30–50 years, although, in NF1 patients, it may occur 10 years earlier on average. It occurs mainly in the proximal limbs, followed by the trunk, head, and neck.

• #99 Peripheral nerve tumors – UpToDate

  https://www.uptodate.com/contents/peripheral-nerve-tumors

  Symptoms and signs – Patients present for evaluation of peripheral nerve tumors because of a soft tissue mass, pain, or focal neurologic findings, approximately in that order of frequency. […] The duration and progression of symptoms or signs are important, as most benign tumors have a longer duration and a slow rate of progression, while malignant tumors tend to progress rapidly in size, amount of pain, and neurologic deficit.

• #100 What Are Malignant Peripheral Nerve Sheath Tumors?

  https://www.rwjbh.org/treatment-care/neuroscience/neurology/conditions/malignant-peripheral-nerve-sheath-tumors/

  Malignant peripheral nerve sheath tumors are most common in young adults and middle-aged adults, and more than half are found in people who have neurofibromatosis 1 (a non-cancerous condition that causes bone deformities). […] In the early stages, malignant peripheral nerve sheath tumors may not have many symptoms. As a tumor grows and presses on the nerves, symptoms may include: Pain, Weakness, A growing lump or mass under the skin.

• #101 Peripheral Nerve Sheath Tumors | Conditions | Penn State Health

  https://www.pennstatehealth.org/services-treatments/peripheral-nerve-sheath-tumors

  Symptoms of peripheral nerve sheath tumors include: […] The outlook for patients with this disease depends on several factors, including tumor size, location and if the tumor is malignant or benign. […] Patients with neurofibromatosis 1 (NF1) have a higher risk of developing malignant peripheral nerve sheath tumors.

• #102 A Discussion of Malignant Peripheral Nerve Sheath Tumors (MPNSTs) – Neurofibromatosis Program

  https://www.uab.edu/medicine/nfprogram/blog/blog-archive/a-discussion-of-malignant-peripheral-nerve-sheath-tumors-mpnsts

  The focus of this months blog post is a discussion of malignant peripheral nerve sheath tumors (MPNSTs), which represent one of the few potentially life-threatening complications of neurofibromatosis type 1. […] MPNSTs occur mostly in teens and young adults with NF1. These tumors usually arise from pre-existing plexiform or nodular neurofibromas and do not originate from cutaneous neurofibromas (i.e., the small tumors on the skin). […] The following are indications that a tumor requires medical evaluation: […] Persistent, unexplained pain. Most neurofibromas are not painful, so occurrence of pain, which is often attributed to other causes, is a sign the tumor should be medically checked. […] Rapid growth of a tumor. Although neurofibromas may grow, the sudden growth of a tumor or growth that is significantly out of proportion to other neurofibromas should be evaluated.

• #103 Peripheral Nerve Sheath Tumors | Neurofibromatosis Center | Washington University in St. Louis

  https://nfcenter.wustl.edu/research/research-areas/peripheral-nerve-sheath-tumors/

  The most common tumors seen in individuals with NF1 are peripheral nerve sheath tumors (cutaneous and plexiform neurofibromas). These tumors are typically slow growing, but can transform into malignant peripheral nerve sheath tumors (MPNSTs). MPNSTs are highly aggressive cancers, which frequently metastasize to other organs. […] Neurofibromas also form and grow in an environment rich in nerves. While not conventionally thought to control tumor development and progression, recent studies have revealed that nerve cells are important drivers of plexiform neurofibroma growth. […] Dr. Yuan Pan is working with Dr. Angela Hirbe to determine how nerves and neuronal hyperactivity control MPNST growth.

• #104 What Are Malignant Peripheral Nerve Sheath Tumors?

  https://www.rwjbh.org/treatment-care/neuroscience/neurology/conditions/malignant-peripheral-nerve-sheath-tumors/

  Malignant peripheral nerve sheath tumors are most common in young adults and middle-aged adults, and more than half are found in people who have neurofibromatosis 1 (a non-cancerous condition that causes bone deformities). […] In the early stages, malignant peripheral nerve sheath tumors may not have many symptoms. As a tumor grows and presses on the nerves, symptoms may include: Pain, Weakness, A growing lump or mass under the skin.

• #105 Malignant Peripheral Nerve Sheath Tumors: Latest Concepts in Disease Pathogenesis and Clinical Management

  https://www.mdpi.com/2072-6694/15/4/1077

  MPNST is the leading cause of premature death in NF1 patients. Clinical symptoms are mainly used to diagnose NF1. […] The risk of post-radiation sarcoma in patients who undergo radiation therapy has been reported to be about 0.06%. Approximately 10–13% of MPNST patients have a history of therapeutic irradiation. […] The probability of malignant progression to MPNST is 10–15%. PN is commonly detected in childhood and grows rapidly during that period. Growth in adulthood is usually indicative of malignancy potential. […] In clinical manifestations, it is difficult to distinguish PN from MPNST since they both exhibit similar neurological symptoms (pain, neurologic impairment, and motor dysfunction) and disfigurement. Some PN patients remain asymptomatic throughout their lives. […] The long-term outcome of radiation therapy results in excellent local control. However, adjuvant radiation therapy is not beneficial in MPNST survival, even though, in some studies, adjuvant radiation has been used to reduce the tumor size in order to make surgery possible.

• #106 Different Pathology of Peripheral Nerve Sheath Tumor in Neurofibromatosis Type 1: 3 Cases

  https://www.thenerve.net/DOIx.php?id=10.21129/nerve.2021.7.2.92

  Neurofibromatosis type 1 (NF1) is an autosomal-dominant genetic disease that predisposes affected individuals to tumors. […] The patient with MPNST died after chemoradiotherapy; the other patients did not experience recurrence for several months. […] MPNST is a rare disease that is very concerning due to its poor prognosis. The incidence of MPNST is approximately 0.001% in the general population. The recurrence rate is approximately 40% to 65%, and metastasis is found in 16% to 39% of patients. The 5-year survival rate is approximately 25% to 42%. […] In case 3, we performed surgical resection, radiotherapy, and chemotherapy, but the patient experienced extremely rapid progression of malignant tumor. […] NF1 patients are at high risk of neoplastic disease; the overall risk of cancer in NF1 patients is 2.7 times higher and the risk of malignancy in 50-year-olds is approximately 20%.

• #107 Malignant Peripheral Nerve Sheath Tumors: Latest Concepts in Disease Pathogenesis and Clinical Management

  https://www.mdpi.com/2072-6694/15/4/1077

  Malignant peripheral nerve sheath tumor (MPNST) is a soft tissue sarcoma with limited therapeutic interventions and a poor prognosis. The main clinical manifestations are pain and numbness; however, they are not specific symptoms, and MPNSTs are difficult to distinguish from other nerve lesions. MPNST is still difficult to diagnose and treat, and the overall prognosis is poor. Although MPNST is a rare disease, the mortality rate is high. The median survival time is largely based on subtypes of MPNST and molecular variations. MPNST development may also be influenced by genetic differences between ethnic groups. […] The average age of onset is around 30–50 years, although, in NF1 patients, it may occur 10 years earlier on average. It occurs mainly in the proximal limbs, followed by the trunk, head, and neck.

• #108 A Discussion of Malignant Peripheral Nerve Sheath Tumors (MPNSTs) – Neurofibromatosis Program

  https://www.uab.edu/medicine/nfprogram/blog/blog-archive/a-discussion-of-malignant-peripheral-nerve-sheath-tumors-mpnsts

  The focus of this months blog post is a discussion of malignant peripheral nerve sheath tumors (MPNSTs), which represent one of the few potentially life-threatening complications of neurofibromatosis type 1. […] MPNSTs occur mostly in teens and young adults with NF1. These tumors usually arise from pre-existing plexiform or nodular neurofibromas and do not originate from cutaneous neurofibromas (i.e., the small tumors on the skin). […] The following are indications that a tumor requires medical evaluation: […] Persistent, unexplained pain. Most neurofibromas are not painful, so occurrence of pain, which is often attributed to other causes, is a sign the tumor should be medically checked. […] Rapid growth of a tumor. Although neurofibromas may grow, the sudden growth of a tumor or growth that is significantly out of proportion to other neurofibromas should be evaluated.

• #109 A Discussion of Malignant Peripheral Nerve Sheath Tumors (MPNSTs) – Neurofibromatosis Program

  https://www.uab.edu/medicine/nfprogram/blog/blog-archive/a-discussion-of-malignant-peripheral-nerve-sheath-tumors-mpnsts

  Change in the consistency of a tumor from soft to hard. Most neurofibromas are soft and spongy, although firm nodular neurofibromas under the skin are not worrisome. […] Treatment of MPNSTs usually involves surgery to resect the tumor, if possible. […] In conclusion, because MPNSTs are difficult to treat, early detection is critically important. Individuals with NF1 should report instances of chronic pain or rapidly growing tumors.

• #110 A Discussion of Malignant Peripheral Nerve Sheath Tumors (MPNSTs) – Neurofibromatosis Program

  https://www.uab.edu/medicine/nfprogram/blog/blog-archive/a-discussion-of-malignant-peripheral-nerve-sheath-tumors-mpnsts

  The focus of this months blog post is a discussion of malignant peripheral nerve sheath tumors (MPNSTs), which represent one of the few potentially life-threatening complications of neurofibromatosis type 1. […] MPNSTs occur mostly in teens and young adults with NF1. These tumors usually arise from pre-existing plexiform or nodular neurofibromas and do not originate from cutaneous neurofibromas (i.e., the small tumors on the skin). […] The following are indications that a tumor requires medical evaluation: […] Persistent, unexplained pain. Most neurofibromas are not painful, so occurrence of pain, which is often attributed to other causes, is a sign the tumor should be medically checked. […] Rapid growth of a tumor. Although neurofibromas may grow, the sudden growth of a tumor or growth that is significantly out of proportion to other neurofibromas should be evaluated.

• #111 A Discussion of Malignant Peripheral Nerve Sheath Tumors (MPNSTs) – Neurofibromatosis Program

  https://www.uab.edu/medicine/nfprogram/blog/blog-archive/a-discussion-of-malignant-peripheral-nerve-sheath-tumors-mpnsts

  The focus of this months blog post is a discussion of malignant peripheral nerve sheath tumors (MPNSTs), which represent one of the few potentially life-threatening complications of neurofibromatosis type 1. […] MPNSTs occur mostly in teens and young adults with NF1. These tumors usually arise from pre-existing plexiform or nodular neurofibromas and do not originate from cutaneous neurofibromas (i.e., the small tumors on the skin). […] The following are indications that a tumor requires medical evaluation: […] Persistent, unexplained pain. Most neurofibromas are not painful, so occurrence of pain, which is often attributed to other causes, is a sign the tumor should be medically checked. […] Rapid growth of a tumor. Although neurofibromas may grow, the sudden growth of a tumor or growth that is significantly out of proportion to other neurofibromas should be evaluated.

• #112 A Discussion of Malignant Peripheral Nerve Sheath Tumors (MPNSTs) – Neurofibromatosis Program

  https://www.uab.edu/medicine/nfprogram/blog/blog-archive/a-discussion-of-malignant-peripheral-nerve-sheath-tumors-mpnsts

  Change in the consistency of a tumor from soft to hard. Most neurofibromas are soft and spongy, although firm nodular neurofibromas under the skin are not worrisome. […] Treatment of MPNSTs usually involves surgery to resect the tumor, if possible. […] In conclusion, because MPNSTs are difficult to treat, early detection is critically important. Individuals with NF1 should report instances of chronic pain or rapidly growing tumors.

• #113 Malignant Peripheral Nerve Sheath Tumors – Rein in Sarcoma

  https://www.reininsarcoma.org/mpnst/

  Malignant schwannoma, also known as a malignant peripheral nerve sheath tumor (MPNST), is a type of soft tissue sarcoma that originates in the lining (sheath) of peripheral nerves that emerge from the spinal cord. […] A malignant transformation of a benign plexiform neurofibroma may first present as new, intensifying or persistent pain localized to the pre-existing mass. In a patient without NF1, a malignant nerve sheath tumor may manifest as pain arising from an entirely new, rapidly enlarging mass. As a result of the tumors mass effect in either etiology, local neurological symptoms of weakness or paresthesia may also develop. […] The most common sites of malignant peripheral nerve sheath tumors include the nerve roots in the proximal extremities and pelvis, especially in the sciatic nerve. […] Depending on the etiology, MPNSTs classically present as either new pain in a pre-existing lesion or pain in an entirely new, rapidly enlarging mass, often located in the proximal extremity.

• #114 Malignant Peripheral Nerve Sheath Tumors: Latest Concepts in Disease Pathogenesis and Clinical Management

  https://www.mdpi.com/2072-6694/15/4/1077

  MPNST is the leading cause of premature death in NF1 patients. Clinical symptoms are mainly used to diagnose NF1. […] The risk of post-radiation sarcoma in patients who undergo radiation therapy has been reported to be about 0.06%. Approximately 10–13% of MPNST patients have a history of therapeutic irradiation. […] The probability of malignant progression to MPNST is 10–15%. PN is commonly detected in childhood and grows rapidly during that period. Growth in adulthood is usually indicative of malignancy potential. […] In clinical manifestations, it is difficult to distinguish PN from MPNST since they both exhibit similar neurological symptoms (pain, neurologic impairment, and motor dysfunction) and disfigurement. Some PN patients remain asymptomatic throughout their lives. […] The long-term outcome of radiation therapy results in excellent local control. However, adjuvant radiation therapy is not beneficial in MPNST survival, even though, in some studies, adjuvant radiation has been used to reduce the tumor size in order to make surgery possible.

• #115

  https://journals.lww.com/jcraniofacialsurgery/fulltext/2022/11000/malignant_peripheral_nerve_sheath_tumor_of_the.78.aspx

  Four patients with diagnosis of malignant peripheral nerve sheath tumor (MPNST) was treated at the Department of Oral and Maxillofacial Surgery (Nanjing Stomatological Hospital, Medical School of Nanjing University) from 2005 to 2020. […] The most common symptom was rapidly enlarging mass with no nerve palsy associated. […] Malignant peripheral nerve sheath tumor has a high degree of malignancy and active growth of tumor tissue. Patients often show tissue swelling and pain caused by compression of surrounding tissue. At the same time, the tumor originated from the peripheral nerve, which can be converted into local numbness or dyskinesia. […] In addition to local tissue swelling, pain and neurological symptoms, MPNST in oral and maxillofacial region can also show swallowing and language disorders.

• #116 Malignant Peripheral Nerve Sheath Tumors: Latest Concepts in Disease Pathogenesis and Clinical Management

  https://www.mdpi.com/2072-6694/15/4/1077

  MPNST is the leading cause of premature death in NF1 patients. Clinical symptoms are mainly used to diagnose NF1. […] The risk of post-radiation sarcoma in patients who undergo radiation therapy has been reported to be about 0.06%. Approximately 10–13% of MPNST patients have a history of therapeutic irradiation. […] The probability of malignant progression to MPNST is 10–15%. PN is commonly detected in childhood and grows rapidly during that period. Growth in adulthood is usually indicative of malignancy potential. […] In clinical manifestations, it is difficult to distinguish PN from MPNST since they both exhibit similar neurological symptoms (pain, neurologic impairment, and motor dysfunction) and disfigurement. Some PN patients remain asymptomatic throughout their lives. […] The long-term outcome of radiation therapy results in excellent local control. However, adjuvant radiation therapy is not beneficial in MPNST survival, even though, in some studies, adjuvant radiation has been used to reduce the tumor size in order to make surgery possible.

• #117 NEUROSARCOMA (MPNST) | Hand Surgery Resource

  https://www.handsurgeryresource.net/neurosarcoma

  Most patients with a MPNST tumor are between 20 and 50 years of age and preset with a complaint of an enlarging mass. […] Pain complaints are variable. […] Diagnosis and treatment are often delayed owing to the absence of symptoms or nonspecific symptoms. […] Tumor growth is aggressive, and the prognosis is poor. […] Symptoms include pain and progressive weakness and numbness in the affected area, lump or swelling, increasing in size and larger than 5 cm. […] Other symptoms such as paresthesias vary depending on the size and location of the tumor. […] There is a 65% chance of tumor recurrence after surgery. […] There is a 40% chance of metastasis upon regrowth, most commonly to the lung. […] The absence of a positive S100 antigen marker is associated with an increased risk of metastasis and death from these malignant nerve tumors.

• #118 Malignant Peripheral Nerve Sheath Tumour – SFA

  https://curesarcoma.org/sarcoma-subtypes/malignant-peripheral-nerve-sheath-tumour/

  Malignant peripheral nerve sheath tumor is a rare and aggressive soft tissue sarcoma that typically arises from peripheral nerves or benign nerve sheath tumors, often associated with neurofibromatosis type 1. […] MPNSTs are typically seen in patients aged 20–50 years; rarely do they arise in children, usually in the setting of NF1. Patients with NF1 are usually younger at the time of diagnosis than patients with sporadic tumors. The presenting symptoms are an enlarging painful or painless mass that may be palpable or identified on imaging studies. When the tumor involves a nerve, the patient may present with neuropathic symptoms such as motor weakness, paraesthesia, or radicular pain. […] MPNST is an aggressive tumor with a poor prognosis. Truncal location, tumor size > 5 cm, local recurrence, and high-grade morphology are all adverse prognostic factors; patients with NF1-associated MPNST appear to have a worse prognosis than patients with sporadic tumors. Malignant triton tumors are particularly aggressive.

• #119

  https://journals.lww.com/jcraniofacialsurgery/fulltext/2022/11000/malignant_peripheral_nerve_sheath_tumor_of_the.78.aspx

  However, due to the high invasive and malignant nature of the tumor itself, the recurrence rate is still as high as 50% to 80%. The incidence of lung, bone and liver metastasis was 33%. […] The factors influencing the prognosis of MPNST were reported in the literature, including tumor size, local recurrence, distant metastasis, history of neurofibroma and family history. […] Due to its high malignancy, local recurrence and distant metastasis of lung and bone tissue often occur, whereas local lymph node metastasis rate is low, so the cervical lymph node dissection is not usually used in maxillofacial MPNST. […] It is of great significance for the prognosis and survival of patients to further radiotherapy and chemotherapy or adopt radiotherapy and chemotherapy when the operation cannot be performed.

• #120 Giant intrapelvic malignant peripheral nerve sheath tumor mimicking disc herniation: A case report

  https://www.spandidos-publications.com/10.3892/mco.2016.1030

  Giant intrapelvic malignant peripheral nerve sheath tumors arising in the sciatic nerve in the pelvic cavity are a rare occurrence and their symptomatology is usually misdiagnosed as intervertebral disc herniation. […] The most common clinical presentation of intrapelvic MPNST consists of radicular and distal pain, paraesthesia and motor deficiencies. […] Since the symptoms are similar to sciatica due to a herniated disk, while imaging of the spine may reveal discopathy, intrapelvic MPNST of the sciatic nerve is easily misdiagnosed. […] Patients with MPNST have a poor prognosis. Adverse prognostic factors include large size, high-grade tumor, proximal location, surgical margin with tumor invasion and NF1. […] Our goal was to emphasize that intrapelvic MPNST, although infrequent, should be included in the differential diagnosis of sciatica, as its symptomatology may mimic disc herniation.

• #121 Cauda equina malignant peripheral nerve sheath tumor presenting with subarachnoid hemorrhage: a case report | Neurocirugía (English edition)

  https://revistaneurocirugia.com/en-cauda-equina-malignant-peripheral-nerve-avance-S2529849624000583

  Malignant peripheral nerve sheath tumors (MPNST) are uncommon aggressive neoplasms, frequently associated with type I neurofibromatosis. […] Patients with MPNST have a poor prognosis with a 5-year survival rate from 16% to 44% with a local recurrence expected in 38-45% of cases. […] The most frequent clinical presentation of spinal canal MPNST is characterized by local or radicular pain and motor disturbances. […] The mean duration from onset of symptoms to preoperative diagnosis is 12.6 months. […] Our case presents notable findings in terms of the patient’s age, acute onset of symptoms, and the unique evidence of surgical subarachnoid hemorrhage (SSAH). […] The acute debut in our case could be explained by hemorrhage with secondary subarachnoid extension of the blood creating increase in the local pressure and roots irritation as the cause of back pain.

• #122 Cauda equina malignant peripheral nerve sheath tumor presenting with subarachnoid hemorrhage: a case report | Neurocirugía (English edition)

  https://revistaneurocirugia.com/en-cauda-equina-malignant-peripheral-nerve-avance-S2529849624000583

  Malignant peripheral nerve sheath tumors (MPNST) are uncommon aggressive neoplasms, frequently associated with type I neurofibromatosis. […] Patients with MPNST have a poor prognosis with a 5-year survival rate from 16% to 44% with a local recurrence expected in 38-45% of cases. […] The most frequent clinical presentation of spinal canal MPNST is characterized by local or radicular pain and motor disturbances. […] The mean duration from onset of symptoms to preoperative diagnosis is 12.6 months. […] Our case presents notable findings in terms of the patient’s age, acute onset of symptoms, and the unique evidence of surgical subarachnoid hemorrhage (SSAH). […] The acute debut in our case could be explained by hemorrhage with secondary subarachnoid extension of the blood creating increase in the local pressure and roots irritation as the cause of back pain.

• #123 Cauda equina malignant peripheral nerve sheath tumor presenting with subarachnoid hemorrhage: a case report | Neurocirugía (English edition)

  https://revistaneurocirugia.com/en-cauda-equina-malignant-peripheral-nerve-avance-S2529849624000583

  MPNSTs are uncommon, aggressive neoplasms commonly associated with NF1 and typically present in young individuals. […] Among spinal hematomas, SSAH has a very low frequency. […] This presentation is usually related to intracranial hemorrhage secondary to trauma or aneurysm rupture, spinal tumors, and less commonly coagulopathies and spinal trauma. […] To our knowledge, this is the first report of SSAH related to intradural lumbar spine MPNST. […] The diagnosis might be challenging and initially considered in youth and NF I patients. Even lumbar disc herniation can mimic its clinical presentation. SSAH is a surgical novel finding on MPNST.

• #124 Giant intrapelvic malignant peripheral nerve sheath tumor mimicking disc herniation: A case report

  https://www.spandidos-publications.com/10.3892/mco.2016.1030

  Giant intrapelvic malignant peripheral nerve sheath tumors arising in the sciatic nerve in the pelvic cavity are a rare occurrence and their symptomatology is usually misdiagnosed as intervertebral disc herniation. […] The most common clinical presentation of intrapelvic MPNST consists of radicular and distal pain, paraesthesia and motor deficiencies. […] Since the symptoms are similar to sciatica due to a herniated disk, while imaging of the spine may reveal discopathy, intrapelvic MPNST of the sciatic nerve is easily misdiagnosed. […] Patients with MPNST have a poor prognosis. Adverse prognostic factors include large size, high-grade tumor, proximal location, surgical margin with tumor invasion and NF1. […] Our goal was to emphasize that intrapelvic MPNST, although infrequent, should be included in the differential diagnosis of sciatica, as its symptomatology may mimic disc herniation.

• #125 Malignant peripheral nerve sheath tumor presenting in the cauda equina: diagnostic and biological pearls. Illustrative case in: Journal of Neurosurgery: Case Lessons Volume 9 Issue 12 (2025) Journals

  https://thejns.org/caselessons/view/journals/j-neurosurg-case-lessons/9/12/article-CASE24723.xml

  Malignant peripheral nerve sheath tumors (MPNSTs) are rare and highly malignant tumors of neural crest origin. No matter their anatomical location, they are difficult to treat and carry a poor prognosis. […] The described diagnostic nuance should be taken into consideration in patients with suspected MPNST of the cauda equina, as these tumors require swift neurosurgical intervention in order to maintain neurological function. Additional treatment modalities include neoadjuvant and adjuvant chemotherapy and radiotherapy. Although improvements in local control and progression-free survival have been reported, the role of radiation therapy and chemotherapy has been underinvestigated due to the rarity of MPNSTs presenting in this region. […] The prognosis is poor, with a 5-year overall survival rate of 15%66% and a 5-year local recurrence rate of 20%85.7%.

• #126 Surgical management of craniospinal axis malignant peripheral nerve sheath tumors: a single-institution experience and literature review | World Journal of Surgical Oncology | Full Text

  https://wjso.biomedcentral.com/articles/10.1186/s12957-023-03227-y

  Malignant peripheral nerve sheath tumor (MPNST) is an exceedingly rare and aggressive tumor, with limited literature on its management. […] The most common presenting symptoms were paresthesia (50%) and visual changes (13%). […] MPNSTs are characterized by aggressive local invasiveness and high rates of both local recurrence and distant metastases. […] When arising within the craniospinal axis, they can cause symptoms secondary to mass effect, resulting in spinal cord compression, cranial nerve palsies, and focal neurologic deficits based on tumor location. […] Patients with primary intradural MPNST often present with insidious neurological symptoms, which are generally attributable to a progressive mass effect on nearby neurovascular structures. When present in the cranium, symptoms include headache, nausea/vomiting, seizures, focal neurological deficits, and/or cranial nerve palsies. When present in the spine, MPNST may cause myelopathic symptoms, pain, motor weakness, sensory deficit/radiculopathy, and bowel/bladder dysfunction.

• #127 Surgical management of craniospinal axis malignant peripheral nerve sheath tumors: a single-institution experience and literature review | World Journal of Surgical Oncology | Full Text

  https://wjso.biomedcentral.com/articles/10.1186/s12957-023-03227-y

  Malignant peripheral nerve sheath tumor (MPNST) is an exceedingly rare and aggressive tumor, with limited literature on its management. […] The most common presenting symptoms were paresthesia (50%) and visual changes (13%). […] MPNSTs are characterized by aggressive local invasiveness and high rates of both local recurrence and distant metastases. […] When arising within the craniospinal axis, they can cause symptoms secondary to mass effect, resulting in spinal cord compression, cranial nerve palsies, and focal neurologic deficits based on tumor location. […] Patients with primary intradural MPNST often present with insidious neurological symptoms, which are generally attributable to a progressive mass effect on nearby neurovascular structures. When present in the cranium, symptoms include headache, nausea/vomiting, seizures, focal neurological deficits, and/or cranial nerve palsies. When present in the spine, MPNST may cause myelopathic symptoms, pain, motor weakness, sensory deficit/radiculopathy, and bowel/bladder dysfunction.

• #128 Surgical management of craniospinal axis malignant peripheral nerve sheath tumors: a single-institution experience and literature review | World Journal of Surgical Oncology | Full Text

  https://wjso.biomedcentral.com/articles/10.1186/s12957-023-03227-y

  Malignant peripheral nerve sheath tumor (MPNST) is an exceedingly rare and aggressive tumor, with limited literature on its management. […] The most common presenting symptoms were paresthesia (50%) and visual changes (13%). […] MPNSTs are characterized by aggressive local invasiveness and high rates of both local recurrence and distant metastases. […] When arising within the craniospinal axis, they can cause symptoms secondary to mass effect, resulting in spinal cord compression, cranial nerve palsies, and focal neurologic deficits based on tumor location. […] Patients with primary intradural MPNST often present with insidious neurological symptoms, which are generally attributable to a progressive mass effect on nearby neurovascular structures. When present in the cranium, symptoms include headache, nausea/vomiting, seizures, focal neurological deficits, and/or cranial nerve palsies. When present in the spine, MPNST may cause myelopathic symptoms, pain, motor weakness, sensory deficit/radiculopathy, and bowel/bladder dysfunction.

• #129 Surgical management of craniospinal axis malignant peripheral nerve sheath tumors: a single-institution experience and literature review | World Journal of Surgical Oncology | Full Text

  https://wjso.biomedcentral.com/articles/10.1186/s12957-023-03227-y

  Malignant peripheral nerve sheath tumor (MPNST) is an exceedingly rare and aggressive tumor, with limited literature on its management. […] The most common presenting symptoms were paresthesia (50%) and visual changes (13%). […] MPNSTs are characterized by aggressive local invasiveness and high rates of both local recurrence and distant metastases. […] When arising within the craniospinal axis, they can cause symptoms secondary to mass effect, resulting in spinal cord compression, cranial nerve palsies, and focal neurologic deficits based on tumor location. […] Patients with primary intradural MPNST often present with insidious neurological symptoms, which are generally attributable to a progressive mass effect on nearby neurovascular structures. When present in the cranium, symptoms include headache, nausea/vomiting, seizures, focal neurological deficits, and/or cranial nerve palsies. When present in the spine, MPNST may cause myelopathic symptoms, pain, motor weakness, sensory deficit/radiculopathy, and bowel/bladder dysfunction.

• #130 Malignant peripheral nerve sheath tumor presenting in the cauda equina: diagnostic and biological pearls. Illustrative case in: Journal of Neurosurgery: Case Lessons Volume 9 Issue 12 (2025) Journals

  https://thejns.org/caselessons/view/journals/j-neurosurg-case-lessons/9/12/article-CASE24723.xml

  Malignant peripheral nerve sheath tumors (MPNSTs) are rare and highly malignant tumors of neural crest origin. No matter their anatomical location, they are difficult to treat and carry a poor prognosis. […] The described diagnostic nuance should be taken into consideration in patients with suspected MPNST of the cauda equina, as these tumors require swift neurosurgical intervention in order to maintain neurological function. Additional treatment modalities include neoadjuvant and adjuvant chemotherapy and radiotherapy. Although improvements in local control and progression-free survival have been reported, the role of radiation therapy and chemotherapy has been underinvestigated due to the rarity of MPNSTs presenting in this region. […] The prognosis is poor, with a 5-year overall survival rate of 15%66% and a 5-year local recurrence rate of 20%85.7%.

• #131 Malignant peripheral nerve sheath tumor symptoms, treatments & forums | PatientsLikeMe

  https://www.patientslikeme.com/conditions/malignant-peripheral-nerve-sheath-tumor

  Common symptoms […] Common symptom Fatigue […] Common symptom Stress […] Common symptom Anxious mood […] Common symptom Depressed mood […] Common symptom Pain

• #132 Peripheral Nerve Sheath Tumors in Dogs | PetCure Oncology

  https://petcureoncology.com/peripheral-nerve-sheath-tumors-in-dogs/

  Peripheral nerve sheath tumors in dogs are typically a single mass. They may be visible on the skin or you may feel a lump below the skin. The mass may be just a few millimeters in size but nerve sheath tumors also can grow much larger. […] A larger tumor could affect a stricken dog’s energy level, making him or her lethargic. He or she also could lose weight, even while maintaining a normal appetite. A larger tumor also could cause nerve impingement, impairing function or limiting a dog’s range of motion in a limb, for instance. A dog might appear to be dragging a limb or may even turn its paw over, walking on his or her knuckles with the pad facing upward, which is often referred to as knuckling. […] Though uncommon, when this type of cancer metastasizes, it will spread to the lungs or the local lymph nodes.

• #133 Malignant peripheral nerve sheath tumor symptoms, treatments & forums | PatientsLikeMe

  https://www.patientslikeme.com/conditions/malignant-peripheral-nerve-sheath-tumor

  Common symptoms […] Common symptom Fatigue […] Common symptom Stress […] Common symptom Anxious mood […] Common symptom Depressed mood […] Common symptom Pain

• #134 Peripheral Nerve Sheath Tumors in Dogs | PetCure Oncology

  https://petcureoncology.com/peripheral-nerve-sheath-tumors-in-dogs/

  Peripheral nerve sheath tumors in dogs are typically a single mass. They may be visible on the skin or you may feel a lump below the skin. The mass may be just a few millimeters in size but nerve sheath tumors also can grow much larger. […] A larger tumor could affect a stricken dog’s energy level, making him or her lethargic. He or she also could lose weight, even while maintaining a normal appetite. A larger tumor also could cause nerve impingement, impairing function or limiting a dog’s range of motion in a limb, for instance. A dog might appear to be dragging a limb or may even turn its paw over, walking on his or her knuckles with the pad facing upward, which is often referred to as knuckling. […] Though uncommon, when this type of cancer metastasizes, it will spread to the lungs or the local lymph nodes.

• #135 Malignant peripheral nerve sheath tumor symptoms, treatments & forums | PatientsLikeMe

  https://www.patientslikeme.com/conditions/malignant-peripheral-nerve-sheath-tumor

  Common symptoms […] Common symptom Fatigue […] Common symptom Stress […] Common symptom Anxious mood […] Common symptom Depressed mood […] Common symptom Pain

• #136 MPNST? — Cancer Survivors Network

  https://csn.cancer.org/discussion/158325/mpnst

  I am hoping to find anyone with Malignant Peripheral Nerve Sheath Tumor and find out about their treatment and diagnosis and any alternative diet or supplements they are using. […] I had 3 large tumors removed from my neck about 2 years ago and have a new one under my jaw that is inoperable. […] I had MPNST of the brain an neck. I am 22 and survivor, I underwent surgeries, chemo and radiation. […] My husband has been diagnosed with this and has had surgery to remove the tumor and is now undergoing 6 weeks of radiation treatment. Total treatment is 60 gy. […] My husband noticed a small lump under his left arm on November 13th last year, by the time he went in for surgery on December 8th the lump had grown to baseball size. It took nearly 2 weeks and two pathology reports to diagnose high grade MPNST.

• #137 MPNST? — Cancer Survivors Network

  https://csn.cancer.org/discussion/158325/mpnst

  We have been told that his „odds” for survival are 45-50% after 5 years. […] I have found that it is so important to take care of myself too during this stressful time in our lives. […] I am hoping to gather information about chemo on MPNST. I understand they are generally not effective against MPNST, but, in browsing the web, I read an article that chemo did work for Epitheliod MPNST for a particular case involving a 62 year old man. […] I had an MPNST of the sinus cavity. […] I am just glad I found this forum since this is such a rare cancer.

• #138 Childhood Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) | Dana-Farber Cancer Institute

  https://www.dana-farber.org/cancer-care/types/childhood-peripheral-nerve-sheath-tumor

  Peripheral nerve sheath tumors, also called neurofibrosarcomas, are malignant tumors that form in the soft tissues surrounding the peripheral nerves, which receive messages from the brain and stimulate voluntary movement. […] The most common symptoms include: Painless swelling or a lump, usually in the arms or legs; Pain or soreness from compressed nerves or muscles; Nerve loss as the tumor grows; Limp or difficulty using the arms, legs, feet, or hands. […] Continued monitoring and care are essential as these tumors can recur, even after aggressive treatment.

• #139 Peripheral nerve tumors – Symptoms and causes – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/peripheral-nerve-tumors/symptoms-causes/syc-20355070

  Symptoms of peripheral nerve tumors vary depending on where the tumors are located and the tissues affected. They include: […] The symptoms of a peripheral nerve tumor develop from direct effects on the main nerve or from the tumor pressing on nearby nerves, blood vessels or tissues. As the tumor grows, it may be more likely to cause symptoms, although tumor size doesn’t always determine effects. […] Peripheral nerve tumors can press against nerves. This can lead to complications. Some may be permanent: […] Numbness and weakness in the affected area. […] Loss of function in the affected area. […] Trouble with balance. […] Pain.

• #140 Peripheral nerve tumors – Symptoms and causes – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/peripheral-nerve-tumors/symptoms-causes/syc-20355070

  Symptoms of peripheral nerve tumors vary depending on where the tumors are located and the tissues affected. They include: […] The symptoms of a peripheral nerve tumor develop from direct effects on the main nerve or from the tumor pressing on nearby nerves, blood vessels or tissues. As the tumor grows, it may be more likely to cause symptoms, although tumor size doesn’t always determine effects. […] Peripheral nerve tumors can press against nerves. This can lead to complications. Some may be permanent: […] Numbness and weakness in the affected area. […] Loss of function in the affected area. […] Trouble with balance. […] Pain.

• #141 Pain as a symptom of peripheral nerve sheath tumors: clinical significance and future therapeutic directions

  https://pmc.ncbi.nlm.nih.gov/articles/PMC2291052/

  Tumors arising from the supporting cells of peripheral nerve sheaths are relatively uncommon neoplasms, and as such many clinicians are unfamiliar with the details of their presentation, diagnosis and management. Further, little is known regarding the pathogenesis of these tumors, how they cause symptoms, and how to treat these symptoms. […] The typical presenting signs and symptoms of a peripheral nerve sheath tumor (PNST) involves some combination of a palpable (or radiographically visible) mass involving a peripheral nerve, loss of nerve function, and/or pain. […] Of clear importance is the ability to differentiate between benign and malignant lesions as early as possible in the clinical work-up and management of these lesions, as they are treated very differently, and exhibit very different clinical and intraoperative behaviors.

• #142 Peripheral Nerve Sheath Tumors — Cancer Survivors Network

  https://csn.cancer.org/discussion/157854/peripheral-nerve-sheath-tumors

  My husband was diagnosed in March 2008 with high grade, stage 3, aggressive, Malignant Peripheral Nerve Sheath Tumor/soft tissue sarcoma a month AFTER the grapefruit sized tumor was surgically removed from his sciatic nerve in his pelvis. […] My husband is now undergoing chemotherapy with plans to have radiation too. […] He has it in the Head Neck area and lost his right ear and all movement of his right side of the face. We are waiting to see if he can get surgery again because the chemo doesn’t look to be helping right now. […] My Mom (69) has just been diagnosed with MPNST originating from her sciatic nerve. This is following the removal of a grapefruit size non-malignant scwannoma from her sacrum less than 9 months ago. She is in Houston and has just started proton therapy (will recieve for 20 days) and 3 rounds of ifosfamide chemo. She has several tumors on the sciatic nerve that has resulted in loss of function of her leg, as well as several small spots on her lungs.

• #143 Malignant peripheral nerve sheath tumor symptoms, treatments & forums | PatientsLikeMe

  https://www.patientslikeme.com/conditions/malignant-peripheral-nerve-sheath-tumor

  Common symptoms […] Common symptom Fatigue […] Common symptom Stress […] Common symptom Anxious mood […] Common symptom Depressed mood […] Common symptom Pain

• #144 MPNST? — Cancer Survivors Network

  https://csn.cancer.org/discussion/158325/mpnst

  We have been told that his „odds” for survival are 45-50% after 5 years. […] I have found that it is so important to take care of myself too during this stressful time in our lives. […] I am hoping to gather information about chemo on MPNST. I understand they are generally not effective against MPNST, but, in browsing the web, I read an article that chemo did work for Epitheliod MPNST for a particular case involving a 62 year old man. […] I had an MPNST of the sinus cavity. […] I am just glad I found this forum since this is such a rare cancer.

• #145 Malignant peripheral nerve sheath tumor symptoms, treatments & forums | PatientsLikeMe

  https://www.patientslikeme.com/conditions/malignant-peripheral-nerve-sheath-tumor

  Common symptoms […] Common symptom Fatigue […] Common symptom Stress […] Common symptom Anxious mood […] Common symptom Depressed mood […] Common symptom Pain

• #146 Malignant peripheral nerve sheath tumor symptoms, treatments & forums | PatientsLikeMe

  https://www.patientslikeme.com/conditions/malignant-peripheral-nerve-sheath-tumor

  Common symptoms […] Common symptom Fatigue […] Common symptom Stress […] Common symptom Anxious mood […] Common symptom Depressed mood […] Common symptom Pain

• #147 Malignant peripheral nerve sheath tumor symptoms, treatments & forums | PatientsLikeMe

  https://www.patientslikeme.com/conditions/malignant-peripheral-nerve-sheath-tumor

  Common symptoms […] Common symptom Fatigue […] Common symptom Stress […] Common symptom Anxious mood […] Common symptom Depressed mood […] Common symptom Pain

• #148 Peripheral Nerve Sheath Tumors — Cancer Survivors Network

  https://csn.cancer.org/discussion/157854/peripheral-nerve-sheath-tumors

  I wanted to let you know that I was just diagnosed with an aggressive MPNST – it was golfball sized, bt also located on my sciatic nerve in my pelvis. […] My dad 43 of age was just got diagnosis with malignant peripheral nerve sheath tumor, in is lower left arm! They removed the tumor Feb 10 that they said was not cancer. it came back a month later! […] He stated to fell numbness is him fingers. […] The dr said that there was NO way that the first time the other dr took it out that it wasn’t cancer!! […] So now he just had another surgery 3/16/11 to do a skin graph bc where they took that stuff out of his arm its basically a whole in his arm! […] Then when he heals from thos surgeries he will start radiation, 5days a week. […] I have malignant nerve sheath tumour!! it’s also called Neurofibrosarcoma.

• #149 Peripheral Nerve Sheath Tumors — Cancer Survivors Network

  https://csn.cancer.org/discussion/157854/peripheral-nerve-sheath-tumors

  The poor prognosis is really scary!! […] your mother’s 15 years survival story is really something I was looking for! It really did bring some hope for me. because i was told by doctors, chances of my survival were 70% for a year and it comes down to only 30% over 5 years time. […] My husband was diagnosed with the same cancer in 2011. […] The massive radiation he recieved caused a systemic fungal infection, which no doctor ever addressed. […] He was told to return for more tests every 6 months, on his lungs and his knee, and he did this for the first year and a half but then decided not to undergo any more as his fungal infection was out of control and all of his attempts to build his immune system back would be destroyed by more radiation from x-rays. […] He died 3 weeks later, his body riddled with cancer.

• #150 Peripheral nerve tumors – Symptoms and causes – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/peripheral-nerve-tumors/symptoms-causes/syc-20355070

  Symptoms of peripheral nerve tumors vary depending on where the tumors are located and the tissues affected. They include: […] The symptoms of a peripheral nerve tumor develop from direct effects on the main nerve or from the tumor pressing on nearby nerves, blood vessels or tissues. As the tumor grows, it may be more likely to cause symptoms, although tumor size doesn’t always determine effects. […] Peripheral nerve tumors can press against nerves. This can lead to complications. Some may be permanent: […] Numbness and weakness in the affected area. […] Loss of function in the affected area. […] Trouble with balance. […] Pain.

• #151 Malignant peripheral nerve sheath tumors

  https://ask-ahd.ahdubai.com/con-20313998

  Malignant peripheral nerve sheath tumors can occur anywhere in the body, but most often occur in the deep tissue of the arms, legs and trunk. They tend to cause pain and weakness in the affected area and may also cause a growing lump or mass. […] Signs and symptoms of malignant peripheral nerve sheath tumors include: Pain in the affected area, Weakness when trying to move the affected body part, A growing lump of tissue under the skin. […] Depending on the location and size of your malignant peripheral nerve sheath tumor, surgery can cause nerve damage and disability. In the case of tumors that occur in the arms and legs, limb amputation may be necessary.

• #152

  https://www.advocatehealth.com/health-services/brain-spine-institute/peripheral-nerve-tumors

  A small percentage of neurofibromas and schwannomas can become malignant peripheral nerve sheath tumors (MPNST). These tumors are fast-growing and often grow on nerves in the legs, arms or pelvis. They can be resistant to chemotherapy treatment and often recur after treatment. […] Each type of peripheral nerve tumor has its own set of symptoms, which depend on the specifics of the individual tumor such as: […] Small, slow-growing tumors may have no symptoms or very mild symptoms. Although symptoms are different for every tumor and every person, some signs and symptoms of many peripheral nerve tumors include: Pain, numbness or tingling in the affected body part, Visible lump or deformed appearance, Loss of movement, Fatigue, Weakness. […] Malignant peripheral nerve sheath tumor treatment usually includes cancer surgery to remove as much of the tumor as possible. In extreme cases, surgery for an MPNST may require partial amputation of an affected limb. Radiation therapy and chemotherapy may be applied before surgery to shrink the tumor, after surgery to remove the rest of the tumor, or both before and after surgery.

• #153

  https://link.springer.com/article/10.1007/s11523-024-01078-5

  In addition to frequent metastasis and disease recurrence, patients with MPNST are also approximately 30 times more likely than the general population to develop secondary malignancies, particularly in the breast, skin, lung, and soft tissues in females as well as skin and myeloid tissues in males. […] The prognosis is poor, with typically rapid growth and metastasis (mainly to the lungs more often than the bone or liver).

• #154 Peripheral Nerve Sheath Tumors — Cancer Survivors Network

  https://csn.cancer.org/discussion/157854/peripheral-nerve-sheath-tumors

  The poor prognosis is really scary!! […] your mother’s 15 years survival story is really something I was looking for! It really did bring some hope for me. because i was told by doctors, chances of my survival were 70% for a year and it comes down to only 30% over 5 years time. […] My husband was diagnosed with the same cancer in 2011. […] The massive radiation he recieved caused a systemic fungal infection, which no doctor ever addressed. […] He was told to return for more tests every 6 months, on his lungs and his knee, and he did this for the first year and a half but then decided not to undergo any more as his fungal infection was out of control and all of his attempts to build his immune system back would be destroyed by more radiation from x-rays. […] He died 3 weeks later, his body riddled with cancer.

• #155 MPNST? — Cancer Survivors Network

  https://csn.cancer.org/discussion/158325/mpnst

  We have been told that his „odds” for survival are 45-50% after 5 years. […] I have found that it is so important to take care of myself too during this stressful time in our lives. […] I am hoping to gather information about chemo on MPNST. I understand they are generally not effective against MPNST, but, in browsing the web, I read an article that chemo did work for Epitheliod MPNST for a particular case involving a 62 year old man. […] I had an MPNST of the sinus cavity. […] I am just glad I found this forum since this is such a rare cancer.

• #156 MPNST? — Cancer Survivors Network

  https://csn.cancer.org/discussion/158325/mpnst

  We have been told that his „odds” for survival are 45-50% after 5 years. […] I have found that it is so important to take care of myself too during this stressful time in our lives. […] I am hoping to gather information about chemo on MPNST. I understand they are generally not effective against MPNST, but, in browsing the web, I read an article that chemo did work for Epitheliod MPNST for a particular case involving a 62 year old man. […] I had an MPNST of the sinus cavity. […] I am just glad I found this forum since this is such a rare cancer.

• #157 MPNST? — Cancer Survivors Network

  https://csn.cancer.org/discussion/158325/mpnst

  I am hoping to find anyone with Malignant Peripheral Nerve Sheath Tumor and find out about their treatment and diagnosis and any alternative diet or supplements they are using. […] I had 3 large tumors removed from my neck about 2 years ago and have a new one under my jaw that is inoperable. […] I had MPNST of the brain an neck. I am 22 and survivor, I underwent surgeries, chemo and radiation. […] My husband has been diagnosed with this and has had surgery to remove the tumor and is now undergoing 6 weeks of radiation treatment. Total treatment is 60 gy. […] My husband noticed a small lump under his left arm on November 13th last year, by the time he went in for surgery on December 8th the lump had grown to baseball size. It took nearly 2 weeks and two pathology reports to diagnose high grade MPNST.

• #158 MPNST? — Cancer Survivors Network

  https://csn.cancer.org/discussion/158325/mpnst

  We have been told that his „odds” for survival are 45-50% after 5 years. […] I have found that it is so important to take care of myself too during this stressful time in our lives. […] I am hoping to gather information about chemo on MPNST. I understand they are generally not effective against MPNST, but, in browsing the web, I read an article that chemo did work for Epitheliod MPNST for a particular case involving a 62 year old man. […] I had an MPNST of the sinus cavity. […] I am just glad I found this forum since this is such a rare cancer.

• #159 MPNST? — Cancer Survivors Network

  https://csn.cancer.org/discussion/158325/mpnst

  We have been told that his „odds” for survival are 45-50% after 5 years. […] I have found that it is so important to take care of myself too during this stressful time in our lives. […] I am hoping to gather information about chemo on MPNST. I understand they are generally not effective against MPNST, but, in browsing the web, I read an article that chemo did work for Epitheliod MPNST for a particular case involving a 62 year old man. […] I had an MPNST of the sinus cavity. […] I am just glad I found this forum since this is such a rare cancer.

Zobacz więcej